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 ABSTRACT 
 A series of experiments were conducted to determine the effects of on-arrival vs. 
delayed respiratory vaccination and exposure to persistently infected bovine viral 
diarrhea virus challenge on health, gain performance, and physiological and 
immunological measurements in newly received stocker cattle. Two experiments 
evaluated timing (d 0 vs. 14) of respiratory, clostridial, or both vaccinations in newly 
received stocker calves during stress-induced immunosuppression. In Exp. 1, calves 
receiving 14-d delayed vaccination of a pentavalent modified-live respiratory virus 
(MLV) vaccine had greater ADG during the 42-d receiving period and antibody titers 
against infectious bovine rhinotracheitis on d 42; however, morbidity rate did not differ. 
In the second study, stress indicated by serum cortisol concentration and 
neutrophil:lymphocyte ratio was greatest on d 0; nevertheless, no differences in 
performance or morbidity were observed for vaccination treatments. Both studies 
provided evidence that on-arrival administration of a pentavalent MLV respiratory 
vaccine to immunocompromised cattle does not mitigate clinical bovine respiratory 
disease (BRD) or improve animal performance because the majority of clinical 
respiratory disease for both studies occurred during the first 14-d and morbidity rate was 
not different when calves were vaccinated on d 0 vs. 14. 
 A third experiment was performed to determine the effects of weaning 
management and subsequent exposure to persistently infected (PI) bovine viral diarrhea 
virus (BVDV) challenge on health, performance, bovine viral diarrhea virus titers, 
peripheral blood leukocytes, and inflammatory cytokines. The objective was to compare 
preconditioned (PC) or auction market (AM) origin cattle, with (PI) or without (CON) 
 continuous exposure to PI-BVDV type 1b challenge in a 2 × 2 factorial arrangement to 
evaluate main effects of management, exposure, and their interaction on health 
parameters and growth performance during a 42-d receiving trial. Preconditioned calves 
that were vaccinated, castrated, and weaned at their origin ranch had greater gain 
performance and reduced BRD morbidity compared to AM calves with unknown history. 
Furthermore, PC cattle had greater antibody titers to BVDV type 1a on d 0, and 
neutrophil:lymphocyte ratio and platelet count were lower during the 42-d receiving 
period. Exposure to PI-BVDV challenge reduced gain from d 28 to 42, perhaps due to an 
additive effect of continuous immune stimulation resulting in nutrients being 
preferentially utilized for immune pathways rather than tissue deposition. A treatment 
interaction was observed for the percentage of chronically ill animals; AMPI had the 
greatest number of chronically ill calves (7.6%), AMCON was intermediate (1.1%), and 
PCCON and PCPI were least (0.4 and 0.3%, respectively). Exposure to PI-BVDV 
challenge increased serum TNF-α concentrations, and IFN-γ concentrations on d 14 and 
were greatest for AMPI, intermediate for PCPI, and least for AMCON and PCCON. The 
increased cytokine concentrations associated with PI-BVDV exposure illustrate a more 
stimulated immune response which has implications for animal health due to taxation of 
the immune system and growth due to a homeorhetic response in which nutrients may be 
preferentially shifted towards immune function rather than tissue growth.  
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CHAPTER I 
INTRODUCTION 
 Bovine respiratory disease (BRD) is a multifaceted syndrome involving 
physiological stress, commingling, and several viral and bacterial pathogens. Despite 
recent advances in biological and pharmaceutical products designed to prevent and 
control the disease, BRD remains the leading cause of feedlot morbidity and mortality 
(Woolums et al., 2005) resulting in increased antibiotic usage, reduced animal well-
being, and decreased growth performance and production efficiency (Holland et al., 
2010). The treatment costs and production losses associated with BRD result in a 
significant economic loss to the beef industry (Irsik et al., 2006) estimated to be at least 
$750 million annually (Griffin, 1997). 
 Several factors contribute to the susceptibility and pathogenesis of BRD, one of 
the most significant being management and marketing of cattle. As calves move through 
the beef production system, stress from handling, weaning, commingling, transport, 
environment, and diet transition can combine synergistically resulting in physiological 
stress and immunosuppression. Furthermore, the estimated adoption rate of management 
factors including weaning (50.2%) or respiratory vaccination (39.4%) in US beef cow-
calf operations remains low (USDA, 2010) because logistical challenges exist, cost and 
risk are a hindrance, and market availability is limited. The physiological stress and 
compromised immune system commonly found in newly received calves may render 
initial vaccination incapable of stimulating an effective immune response (Edwards, 
2010). 
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 Commingling from the marketing process can increase exposure to one of the four 
viruses known to be associated with BRD: 1) infectious bovine rhinotracheitis, 2) bovine 
viral diarrhea virus (BVDV), 3) parainfluenza-3, and 4) bovine respiratory syncytial 
virus. Bovine viral diarrhea virus is among the most economically important (Griffin, 
1997) of the respiratory viruses, causing severe acute disease (Carman et al., 1998) or 
indirect effects of immunosuppression (Welch, 1995). Immunosuppression caused by 
acute BVDV infection can allow otherwise commensal bacterial inhabitants of the upper 
respiratory tract such as Manheimia haemolytica or Pasteurella multocida, to colonize 
the lower respiratory tract and lungs becoming pathogenic. Calves born persistently 
infected (PI) with BVDV are a primary transmission source (Houe, 1995); however, 
reports on the effects of PI-BVDV exposure on health, production and economic 
parameters of feeder cattle are: 1) limited; perhaps due to the challenging logistics of 
coordinating these studies, and 2) conflicting; because the management and immune 
status of experimental animals may differ and the amount (organisms/mL) and virulence 
of the BVDV strain being continually shed by PI challenge animals is varied. 
 The purpose of this series of experiments was to examine the physiological and 
immunological status of newly received calves, determine the effects of on-arrival versus 
delayed respiratory vaccination in high-risk, immunosuppressed calves, and observe the 
health, performance, humoral and cell-mediated immune response of calves with 
different physiological and immunological circumstances and subsequent exposure to PI-
BVDV challenge. 
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CHAPTER II 
REVIEW OF LITERATURE 
Overview of Bovine Respiratory Disease in the US 
 Bovine respiratory disease (BRD) is a multifaceted syndrome involving 
physiological stress, commingling, and several viral and bacterial pathogens. Despite 
recent advances in biological and pharmaceutical products designed to prevent and 
control the disease, BRD remains the leading cause of feedlot morbidity and mortality 
(Woolums et al., 2005) resulting in increased antibiotic usage, reduced animal well-
being, and decreased growth performance and production efficiency (Holland et al., 
2010). Gardner et al. (1999) was among the first studies to demonstrate carcass quality 
being negatively impacted by BRD, and more recently Schneider et al. (2009) reported 
that in cattle treated for BRD, 16% fewer graded USDA choice than non-treated animals. 
Although difficult to assess, the treatment costs and production losses associated with 
BRD result in a significant economic loss to the beef industry (Irsik et al., 2006) 
estimated to be at least $750 million annually (Griffin, 1997). 
 Bovine respiratory disease can occur in cattle of all ages and during all beef 
production systems; however, the most susceptible animals are physiologically stressed, 
immature feeder cattle that are recently weaned from their dam, subjected to 
commingling with cattle from other herds, and transported by truck to a stocker or 
finishing program where a transition in diet typically occurs. The beef production system 
is separated into distinct production segments of cow-calf, stocker, feedlot, packer, 
retailer, and ultimately, the beef consumer. Ownership frequently changes with each 
segment; therefore, an informational disconnect exists regarding the performance, 
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efficiency and health of calves as they move from one segment to another. This 
fundamental segmentation of the beef production system increases the susceptibility to 
BRD in the beef industry because inherent stressors exist as calves progress from one 
production segment to another. With the traditional auction market system, sellers convey 
health risk of their calves to the buyer with little consequence because communication 
among buyer and seller is rare. Another marketing roadblock for mitigation of BRD is the 
limited value-added marketing opportunities available to small cow-calf producers that 
wish to invest labor and resources in vaccination and management practices that can 
greatly reduce BRD health risk. Furthermore, because the estimated average herd size in 
the US is small (average = 42.9; USDA, 2007), a logistical challenge exists. Most cow-
calf producers do not annually produce enough calves needed to comprise a full truck-
load lot of ~22,500 kg (i.e. 90 calves weighing 250 kg), which limits options for direct-
marketing or retained-ownership. Therefore, the commodity-based auction market system 
is the most common method of feeder cattle sale in the US (USDA, 2010), and most 
calves are sold individually (Troxel et al., 2002). Selling feeder cattle individually 
contributes to commingling because cattle buyers must assemble a full truck-load lot with 
cattle from multiple cow-calf operations, and commingling results in increased stress and 
BRD morbidity (Step et al., 2008) because the social hierarchy of a group must be re-
established and exposure to novel pathogens is more likely. 
 The BRD mortality rate in US feedlots has remained relatively unchanged over 
the past 3 decades (Miles, 2009). One cause of the feedlot mortality rate remaining 
unchanged despite significant improvements in vaccine efficacy and antimicrobial 
availability may be the low adoption rate by beef producers of preconditioning 
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management practices that reduce physiological stress and improve disease resistance. 
According to the USDA Beef 2007-08 survey of US cow-calf producers, the estimated 
adoption rate of several cow-calf health management factors including castration 
(49.5%), weaning (50.2%), and respiratory vaccination (39.4%) remains low (USDA, 
2008; USDA, 2010) and increases in the adoption rate of these management practices 
were not observed from the previous decade (Beef ’97; USDA, 1997). 
 The pathogenesis of BRD typically occurs in a distinctive step-wise manner. 
Initially, stress from weaning, marketing, and transport of feeder cattle results in 
immunosuppression during a time of extensive commingling when potential viral 
pathogen exposure is increased, and naïve, immunosuppressed calves are more 
susceptible to viral pathogens associated with BRD. The 4 primary viral pathogens 
associated with BRD include: 1) bovine herpesvirus-1 (also known as infectious bovine 
rhinotracheitis virus; IBRV), 2) bovine viral diarrhea virus (BVDV), 3) parainfluenza3 
virus (PI3V), and 4) bovine respiratory syncytial virus (BRSV). Immunosuppression 
resulting from concurrent management stress and viral infection in calves allow 
otherwise commensal bacteria inhabiting the respiratory tract to defeat a compromised 
immune response and proliferate extensively in the nasopharnyx and bovine lung 
resulting in “shipping fever” pneumonia (Hodgson et al., 2005). Furthermore, co-
infection of viral and bacterial respiratory pathogens results in viral-bacterial synergy 
(Ohmann and Babiuk, 1985). As many as 5 different bacterial species, both Gram-
negative and Gram-positive, are described today in their involvement of BRD. The most 
common bacterial pathogen associated with BRD is Manheimia haemolytica serotype 1 
(Pandher et al., 1998); however, Pasteurella multocida, and Haemophilus somnus are less 
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frequently isolated. The unique virulence factors of each bacterium, combined with the 
host immune response can cause significant inflammation resulting in moderate to severe 
lung damage, morbidity or mortality of the host. 
 Vaccination with an efficacious, multivalent respiratory vaccine containing 
antigen strains of IBRV, PI3V, BVDV, and BRSV can be highly effective at preventing 
BRD if administered to an immunocompetent animal (Perino, 1996). However, the 
efficacy of on-arrival vaccination in high-risk, newly received calves is questionable 
(Perino and Hunsaker, 1997) because these calves may have been previously exposed to 
viral pathogens during the marketing process and disease progression may be at a period 
where vaccination is unable to provide protection. 
Effects of Physiological Stress on Stocker and Feedlot Cattle 
Overview and Potential Biomarkers of Stress and Disease 
 The concept of stress can be traced to Empedocles, a Greek philosopher during 
the fifth century B.C. In the late 1930s, an endocrinologist named Hans Selye is credited 
as the first person to use the term stress as it pertains to modern understanding. Selye 
defined stress as “the body’s nonspecific response to a demand placed on it”. In general, 
stress is any external or internal challenge that disrupts the internal environment 
(Sheridan et al., 1994). As our understanding of physiological stress has improved, its 
role in growth regulation, immunosuppression and disease susceptibility has as well. 
 The most significant impact of stress is the negative effect it has on feed intake 
and immunocompetency (Loerch and Fluharty, 1999), both of which may have a direct 
role in the development of BRD. Loerch and Fluharty (1999) identified 5 consequences 
when stressors are manifested in cattle: 1) transient endocrine responses are likely, 2) 
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products of energy and protein metabolism may be altered, 3) appetite and growth rate 
are affected, 4) digestion and rumen function may be compromised, and 5) an animal’s 
immune system may be challenged. Furthermore, a review by Grandin (1997) postulated 
2 broad categories of stress in cattle: 1) psychological stress caused by commingling, 
handling or fear, and 2) physical stress caused by hunger, disease or injury. 
 Stress stimuli associated with either category can result in physiological alteration 
by activating the hypothalamic-pituitary adrenal axis leading to increased serum or 
plasma levels of glucocorticoids. Glucocorticoids such as cortisol have been linked to 
immunosuppression (Roth, 1985) and thus, the potential for increased disease 
susceptibility in cattle. However, changes in cortisol concentrations in response to 
different stress stimuli commonly encountered during the beef production system are 
varied. Several studies report stress-induced increases in cortisol concentrations of cattle 
(Kegley et al., 1997; Tyler and Cummins, 2003; Gupta et al., 2005), and Anglen et al. 
(2003) observed animals that underwent restraint stress failed to mount a normal immune 
response, which resulted in increased susceptibility to a subsequent pathogen challenge. 
Crookshank et al. (1979) reported that corticosteroids were most responsive to transport 
stress; however, other trials reported no differences in cortisol concentration when 
subjected to weaning (Lefcourt and Elsasser, 1995) or transport (Galyean et al., 1981) 
stress. 
 More recently, products of the pro-inflammatory response have been identified as 
potential biomarkers that may respond to host stress or immune challenge. Acute phase 
proteins (APP) such as haptoglobin, fibrinogen, ceruloplasmin, or serum amyloid-A are 
produced and secreted by the liver and have been measured in the blood of animals 
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subjected to transport, commingling or weaning stress because the rate of synthesis of 
APP can increase several hundredfold when influenced by pro-inflammatory cytokines 
(Klasing and Korver, 1997). Arthington et al. (2003) investigated the effect of 
transportation and commingling on measures of the APP response of newly weaned beef 
calves and reported that transported calves had greater serum amyloid-A, fibrinogen, and 
ceruloplasmin concentrations, yet significantly lower haptoglobin concentrations than 
non-transported controls.  Haptoglobin levels may also correlate with clinical respiratory 
disease; Wittum et al. (1996) reported that feedlot calves treated for BRD had decreased 
serum haptoglobin concentrations from initial to final examination compared to calves 
never receiving antibiotic treatment.  Although these APP are commonly used as 
biomarkers to determine the incidence of stress in cattle, their effects on disease 
pathology is less clear.  
 Interferon-γ is involved in innate immunity serving as a macrophage-activating 
cytokine when it is released by natural killer cells responding to infected or stressed host 
cells, and adaptive immunity when released by T-cells subsequent to antigen recognition 
(Abbas, 2007). Interferon-γ levels are responsive to stressors such as castration (Fisher et 
al., 1997), weaning (Hickey et al., 2003), and endotoxin challenge (Carroll et al., 2009; 
Kahl and Elsasser, 2006).  
 Another biomarker for stress and disease is total and differential leukocyte cell 
concentrations of blood. These cells of the immune system include neutrophils, 
lymphocytes, monocytes, eosinophils, and basophils that each comprise a unique role in 
innate and adaptive immunity. Increases in the concentration of these cell types is 
indicated with the suffix “philia” (i.e. neutrophilia), and is generally attributed to 
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inflammation and immune stimulation (Merck, 1998). Conversely, decreases are 
indicated by the suffix “penia” (i.e. neutropenia) and this condition is often associated 
with endogenous stress because resulting corticosteroids and pro-inflammatory cytokines 
mediate lysis of leukocytes. Although perhaps less extensively researched in the bovine 
model, an increased neutrophil:lymphocyte (N:L) ratio is implicated as an indication of 
shipping stress in pigs (McGlone et al., 1993) and social stress in chicks (Gross and 
Siegel, 1983). 
Interaction of Stress and Immunity 
 Produced primarily by LPS-stimulated macrophages and T-cells, TNF-α mediates 
inflammation and recruitment of immune cells to areas of infection, especially during 
endotoxin infection; thus TNF-α regulates components of both innate and adaptive 
immunity. Carroll et al. (2009) observed that both TNF-α and IL-6 concentrations 
increased following endotoxin challenge in calves, and the magnitude of increase was 
greater for calves weaned at 250 d of age versus early-weaned at 80 d of age and shipped 
to a receiving facility.  
 In a review of stress and immunity in swine and cattle, Salak-Johnson and 
McGlone (2007) proposed that hormonal and immunological products influenced by 
physiological stress such as cortisol, IFN-γ, and IL-4, modulate T helper cell 
differentiation, thereby influencing the direction of the immune response (i.e. humoral vs. 
cell-mediated). Activated CD4+ T lymphocytes differentiate into distinct subsets called T 
helper1 (Th1) and T helper2 (Th2) cells during priming of immature CD4+ T 
lymphocytes, and IFN-γ and IL-4 influence the differentiation process (Mosmann and 
Coffman, 1989). If a T lymphocyte differentiates into a Th1 effector cell, these cells both 
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secrete and are regulated by IFN-γ, which activate CD8+ cytotoxic T cells (cell-mediated 
immunity); whereas, Th2 effector cells activate B cells to produce antibodies (humoral 
immunity) and are regulated by and secrete IL-4, which inhibits Th1 (Coffman, 2006). 
Furthermore, glucocorticoids inhibit many pro-inflammatory cytokines and may favor a 
Th2 or humoral immune response (Wiegers et al., 2005). Salak-Johnson and McGlone et 
al. (2007) concluded that stress may shift the balance between Th1 and Th2 immune 
response, and the conflicting reports of stress and immune interactions in animals may be 
partially explained by the type and duration of stressor, age, genetics, and social status of 
experimental animals used within and among studies.  
 Filion et al. (1984) investigated the role of stress in the induction of pneumonic 
pasteurellosis of calves challenged with respiratory virus (IBR) or bacteria (Pastuerella 
haemolytica). Calves subjected to weaning, transportation, and handling in a feedlot were 
more susceptible to IBR, but not Pastuerella haemolytica challenge. Nevertheless, 
interactions of stress and viral-bacterial synergy in BRD have been described by Hodgson 
et al. (2005).  In their review, 2 unique mechanisms by which stress-induced 
corticosteroids may directly and indirectly modulate viral-bacterial synergy which 
contributes to BRD were identified. First, corticosteroids may directly inhibit the pro-
inflammatory responses induced by increased toll-like receptor expression through 
inhibition of transcriptional regulators NFκB and AP-1. Additionally, corticosteroids may 
indirectly regulate the pro-inflammatory response because of their effects on T cell 
development and increased IL-10, an anti-inflammatory cytokine. The authors concluded 
that stress has a significant impact on prevalence and severity of respiratory disease in 
human and animal models.  
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 Babiuk et al. (1987) treated newly received calves intranasally or intramuscularly 
with recombinant bovine interferon-α, an immunomodulator and inhibitor of viral 
replication, 48 h prior to challenge with IBR, followed 4 d later with Pastuerella 
haemolytica challenge. In this study, interferon-α administration greatly reduced clinical 
BRD, mortality, weight loss, and mean lung score indicated by pneumonic lesions upon 
necropsy. Furthermore, evidence of bacterial-viral synergy existed for control treatments 
not receiving interferon-α; these animals exhibited increased clinical illness score and 
temperature following d 0 IBR challenge, and these indices were further increased 
immediately following Pastuerella haemolytica challenge on d 4.  
 The modulation of humoral and cell-mediated immune response resulting from 
stress-induced physiological alterations, and the impact on vaccine response and disease 
outcome in newly received beef cattle warrants further investigation. 
Interaction of Stress and Growth 
 Stimulation of the immune system can also be considered a stressor and research 
indicates the immune response to endotoxin challenge can cause a metabolic shift to 
repartition nutrients away from tissue deposition in favor of immunity (Elsasser et al., 
1995). Several pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α), 
interferon-γ (IFN-γ), and interleukin-6 (IL-6) have been shown to be responsive to stress 
stimuli and are critical products of the immune response during an infectious challenge, 
yet can impair growth either directly by acting on tissues or indirectly through their 
effects on the endocrine system (Klasing and Korver, 1997). 
 Moreover, growth hormone (GH) and insulin-like growth factor-I (IGF-I) are 
critical in regulating growth and tissue deposition (Spurlock, 1997), and these hormones 
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are inversely altered during endotoxin challenge. An endotoxin challenge study using a 
mouse model reported decreased levels of plasma GH returning to baseline within 24 h; 
however, IGF-I remained low at 24 h (Fan et al., 1995). Therefore, because blood 
concentrations of TNF-α are elevated during endotoxin challenge, this would suggest 
increased TNF-α levels being correlated with decreased GH and IGF-I. Johnson (1997) 
reviewed pro-inflammatory cytokine regulation of growth and proposed that anorectic 
and metabolic effects of immunological challenge occur because: 1) several bacterial and 
viral pathogens stimulate leukocytes to synthesize and secrete cytokines, 2) animals with 
either clinical or subclinical infections are anorectic, 3) exogenous inflammatory stimuli 
and recombinant cytokines, when injected into animals, have anorectic and metabolic 
properties that characterize immunological stress, 4) bona fide receptors for cytokines are 
present in disparate nonimmune tissues, and 5) the anorectic properties of IL-1 are 
blocked by a specific receptor antagonist. 
 Klasing and Korver (1997) reviewed the effects of leukocytic cytokine immune 
stimulation by both pathogens and experimentally-induced cytokine levels on growth 
rate, feed intake, and feed efficiency. The authors refer to direct evidence of pro-
inflammatory cytokines as mediators of growth in experiments which closely duplicate 
the qualitative and quantitative aspects of cytokine release in vivo (Klasing et al., 1987). 
In this series of experiments (Klasing et al., 1987), cortisol and IL-1 concentrations in 
immunologically challenged chicks were greater than in non-challenged controls. 
Furthermore, to determine the influence of cortisol and IL-1 on protein degradation and 
synthesis, skeletal muscles were incubated in the presence of cortisol and IL-1 at 
concentrations similar to those seen after immune challenge. It was observed that cortisol 
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did not affect the rate of protein degradation; however, rate of protein synthesis was 
reduced compared to control. Conversely, IL-1 did not affect rate of protein synthesis but 
resulted in a 24% increase in protein degradation compared to control. In addition to 
modulation of protein synthesis and degradation, cytokines can impair growth through 
induction of anorexia (Plata-Salaman, 1996) and Yang et al. (1994) observed synergistic 
effects of TNF-α and IL-1 in inducing anorexia in rats. Direct and indirect effects of pro-
inflammatory cytokines may decrease feed intake by more than 50% during acute disease 
challenge (Klasing and Korver, 1997). 
Identified Stressors in Beef Cattle Management 
Weaning 
 Weaning is one of the most stressful events encountered in beef calves. Weaning 
can be described two-fold: 1) to accustom a young animal to take nourishment other than 
by suckling, and 2) to detach from that to which one is strongly habituated or devoted. As 
calves mature they transition from a diet consisting primarily of milk, to a diet consisting 
of forage, grain, or both. Although necessary to facilitate standard beef production 
practices, weaning results in psychological (Price et al., 2003) and physiological (Hickey 
et al., 2003) stress, and recently weaned, newly received calves must learn to consume 
feed and water from a bunk or trough. Hickey et al. (2003) evaluated N:L ratio, plasma 
cortisol and APP concentration and IFN-γ production in abruptly weaned calves. The N:L 
ratio was increased and IFN- γ response to an antigen, keyhole limpet haemocyanin, was 
reduced for weaned calves versus control; however, no differences were observed for 
cortisol, haptoglobin, or fibrinogen in this experiment. Arthington et al. (2008) evaluated 
measures of stress and performance in 96 steers over a 2-year period in 4 weaning 
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management treatments: 1) control: weaned on the day of shipment, 2) creep-fed: 
allowed free-choice access to concentrate before weaning and shipment, 3) preweaned: 
weaned and provided supplemental concentrate on pasture before shipment, and 4) early-
weaned: weaned at 70 to 90 d of age and kept on pasture. Overall ADG was greater for 
early-weaned vs. control steers during the 29-d receiving period. Before shipment (d 0), 
plasma ceruloplasmin concentration was less for control vs. early-weaned steers; 
however, subsequent to shipment on d 15 and 22, ceruloplasmin was greater for control 
vs. early-weaned steers. Plasma haptoglobin concentrations tended to be greater for 
creep-fed vs. preweaned calves, but no other differences in haptoglobin concentrations 
were observed. In a subsequent experiment (Carroll et al., 2009), a more intensive 
investigation into the immunological response of early-weaned (80 d of age) vs. normal-
weaned (250 d of age) calves was conducted after endotoxin challenge. Serum samples 
were analyzed for TNF-α, IFN-γ, IL-1β, IL-6, cortisol, ceruloplasmin, and haptoglobin. A 
weaning × time interaction was observed for TNF-α, IL-1β, IL-6, and ceruloplasmin; 
these indices were greater for normal-weaned vs. early-weaned calves subsequent to 
endotoxin challenge. Furthermore, a weaning effect was reported for haptoglobin, with 
serum concentrations being greater for normal-weaned. The authors concluded that the 
immune system of early-weaned calves appears to be more competent in responding to 
pathogen challenge than normal-weaned calves. 
Transportation 
 Transportation of cattle by truck to and from the different cow-calf, stocker, and 
feedlot segments is yet another inherent stressor associated with the beef production 
system. Blecha et al. (1984) performed research on the effects of transportation stress and 
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the immune response in which steers were either shipped 700 km to a feedlot or remained 
at the origin ranch. Transported steers had greater total leukocytes and neutrophils; 
however, cortisol concentrations did not differ. Lymphocyte blastogenic responses were 
reduced after transport; whereas, monocyte phagocytosis and packed cell volume were 
not affected by transportation. Evidence also suggests that confinement associated with 
the transportation process may play a significant role in transit stress. Phillips (1984) 
observed increased concentrations of fibrinogen when steers were shipped 400 km and 
confined in novel surroundings for 15 h, yet this increase was not different from steers 
that were confined without transport. Buckham Sporer et al. (2008) observed several 
alterations in physiological blood parameters following a 9-h truck transportation of beef 
bulls. Blood was collected at -24, 0, 4.5, 9.75, 14.25, 24 and 48 h from initiation of 
transport (0 h). Plasma concentrations of haptoglobin and fibrinogen were decreased with 
the onset of transportation stress. Conversely, plasma cortisol increased sharply by 4.5 
and 9.75 h after transport, returning to sub-baseline at 14.25 h. Furthermore, total 
leukocytes increased in response to transportation stress. Although effects on these 
measurements beyond 48-h were unknown, rapid, acute physiological changes were 
clearly evident and garner potential as biomarkers for stress and disease. Stanger et al. 
(2005) performed a similar transportation stress study; however, blood collection 
occurred 48 h before transport, immediately following a 72 h transport event, and 6 d 
thereafter (216 h). In this study, IFN-γ production did not differ; whereas, total leukocyte 
concentration following transport decreased transiently at 72 h and returned to near 
baseline values by 216 h. To determine effects of weaning and transportation on APP 
response, Qiu et al. (2007) evaluated blood APP concentrations periodically in 3 breeds 
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of cattle. Blood samples were collected at weaning and at 24 and 72 h after weaning. 
Additionally, blood was collected immediately before shipment, upon arrival, and 24 and 
72 h after arrival. Haptoglobin and fibrinogen concentrations were significantly increased 
at 72, but not 24 h after weaning. In response to transportation stress, haptoglobin 
concentrations were least prior to shipment, intermediate for on-arrival and 72 h after 
shipment, and greatest 24 h after shipment. Fibrinogen was increased on-arrival and 72 h 
post-shipment, but not 24 h after shipment, compared to pre-shipment fibrinogen 
concentrations. 
Castration 
 Castration is necessary to reduce aggressive and sexual behavior and improve 
meat quality in male cattle, yet the practice causes pain and stress that temporarily 
reduces performance (Fisher et al., 1996), and the performance reduction due to 
castration is greater in older bulls that are also experiencing weaning stress (Peterson et 
al., 1989). Bretschneider (2005) reported that castration closer to birth resulted in less 
weight loss for the 30-day period following castration. The immune status may also be 
altered by castration, as evidenced by increased leukocytes in the blood for castrates vs. 
controls (Chase et al., 1995), and the incidence of BRD has been reported to be much 
greater in calves castrated on arrival at a feedlot (Daniels et al., 2000). 
 Fisher et al. (1997) determined the effects of castration on cortisol concentration, 
in vitro IFN-γ production, leukocyte concentration, and plasma haptoglobin and 
fibrinogen concentrations. On d 1, surgically castrated animals had lower IFN-γ 
production and greater neutrophil and N:L ratio compared to control. Plasma haptoglobin 
on d 1 and 3 and fibrinogen concentrations on d 3 and 7 were increased for castrated 
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animals. Growth performance was also affected by castration; ADG was less for the first 
7 d in surgically castrated animals. Their results indicate significant physiological 
alterations in response to surgical castration; whereas, performance was transiently 
reduced in castrated animals. 
Commingling 
 A less investigated area of management research is the effect of commingling 
cattle on health and performance. To mitigate the effects of commingling and marketing 
stress, single-source cattle are purchased from larger cow-calf ranches through direct-
marketing; however, commingling is inherent in the auction market process because 
cattle from small cow-calf farms are often sold one at a time, and an order buyer 
purchasing cattle for a stocker of feedlot operation must assemble larger group lots 
weighing ~22,727 kg to facilitate a full truckload. The commingling of cattle results in 2 
primary issues: 1) potential exposure to un-encountered pathogens increases, and 2) the 
hierarchy of the newly assembled group must be established resulting in increased 
psychological and physiological stress. Because commingling during the marketing 
process both increases the potential of viral pathogen exposure and increases stress, acute 
infection with respiratory viruses is more likely because stress-induced 
immunosuppression allows viruses to evade host immune defense mechanisms (Sheridan 
et al., 1994). Step et al. (2008) evaluated effects of health and performance in beef calves 
from a single-source ranch (RANCH) either weaned and immediately shipped to a feedlot 
(WEAN), weaned and kept on the ranch for 45 d before shipment without receiving any 
vaccinations (WEAN45), weaned and kept on the ranch for 45 d before shipment and 
vaccinated with a MLV respiratory vaccine (WEANVAC45), procured and assembled 
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through several auction markets (MARKET), or a commingled group (COMM) 
containing a portion of RANCH and MARKET origin cattle. Regardless of weaning or 
vaccination status, calves originating from RANCH tended to have greater ADG than 
COMM or MARKET calves for the 42-d receiving period. Clinical morbidity was 
greatest for MARKET, intermediate for COMM, and least for RANCH. Gupta et al. 
(2005) observed increased plasma cortisol, albumin, urea, and nonesterified fatty acids in 
14 mo-old Holstein-Friesian steers that were subjected to repeated regrouping and 
repenning. Arthington et al. (2003) observed effects of transport and commingling in 
newly weaned calves on plasma fibrinogen, ceruloplasmin, haptoglobin, and cortisol 
concentrations. No differences were observed for commingling in this study; however, 
commingling was not extensive, consisting of 2 outsourced steer calves being placed in 
the commingled-designated pens. Transportation effects were reported for fibrinogen in 
experiment 1 and haptoglobin in experiment 2; both of these APP increased after 
transport. 
Effects of Preconditioning Management on Bovine Respiratory Disease and Growth 
Performance 
 Preconditioning is a comprehensive management practice first identified in the 
1960s designed to reduce the incidence and susceptibility to BRD during the stocker and 
finishing segments of the beef production system. The negative effects of stress are 
mitigated through preconditioning management; however, this must occur during a 
critical time period before marketing and transport to a stocker operation or feedlot 
occurs. Although the specific requirements of different preconditioning programs may 
vary, typical requirements include weaning calves on their origin ranch for a specified 
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time (i.e. ≥ 45 d), vaccinating against clostridial (Clostridium chauvoei-septicum-novyi-
sordellii perfringens type C & D)  and  respiratory (IBR, BVDV type 1 & 2, PI3V, 
BRSV) antigens, treatment with anthelmintic, castration, dehorning, and training to 
consume feed from a bunk and water from a trough before being marketed or transported 
to a stocker or feedlot facility (Cole, 1985; Duff and Galyean, 2007). Each of these 
preconditioning requirements functions to reduce stress and disease risk in preparation 
for the stocker or feedlot environment. For example, in the preconditioned calf, weaning 
stress is reduced and overcome on the ranch of origin before shipping and commingling 
occurs. This mitigates the additive effect of multiple stressors by shifting stress 
occurrences earlier (ie. weaning stress on the ranch of origin rather than during transport 
to a feedlot with concurrent stressors). Justifiably so, preconditioned cattle are more 
valuable than non-preconditioned cohorts. Net return for preconditioned vs. non-
preconditioned steers selling in a Kansas auction market from 1999 to 2004 was 
estimated between $14.28 (winter) and $31.84 (fall)/animal depending on market 
conditions, calf weight and condition (Dhuyvetter et al., 2005). Whereas, the estimated 
$40 to $60/animal value of preconditioned cattle in the feedlot is considerably greater 
than the estimated net return from marketing preconditioned calves (Dhuyvetter et al., 
2005).  
 Although research is surprisingly limited, several studies demonstrate that 
preconditioning management reduces the incidence of BRD and increases gain 
performance. In a trial conducted by Clark et al. (2006), crossbred beef steers of low- 
(preconditioned) or high-risk for BRD were used to evaluate differences in health and 
performance. Preconditioned calves had greater average daily gain (ADG) during the 
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finishing period than high-risk auction market calves of unknown history; however, no 
differences in performance were observed during the 28-d receiving period. Antibiotic 
treatment cost was also reduced, averaging $15.55 and $0.26/steer for high- and low-risk 
cattle groups, respectively. Seeger et al. (2008) observed that auction market steers of 
unknown origin or health history gained 0.18 kg/d less during a finishing period than 
weaned beef calves receiving a health protocol on their origin ranch prior to marketing; 
however, an unequal number of calves testing positive for PI-BVDV remained in their 
treatment pens during the trial which may have confounded results. Another study 
(Macartney et al., 2003) reported that calves of unknown health history had greater 
morbidity compared with those administered health protocols prior to marketing. 
Furthermore, Roeber et al. (2001) observed that cattle originating from preconditioning 
programs had fewer hospital visits than cattle originating from auction markets. Earlier 
research conducted by Pritchard and Mendez (1990) suggested that non-preconditioned 
calves may fully compensate for initial performance loss by the end of the feeding period; 
however, the non-preconditioned cattle used in that experiment would be considered low-
risk by current industry accepted standards because they were maintained as a single-
source and were not subjected to stressors associated with the auction market system. 
Overview of Bovine Viral Diarrhea Virus and its role in Bovine Respiratory Disease 
 Bovine viral diarrhea virus is a critical viral pathogen that can adversely affect 
reproduction, performance and health of beef cattle from the point of conception through 
the finishing phase of the beef cattle industry. A member of the pestivirus genus within 
the Flavivirus family (Ridpath, 2008), BVDV is classified into genetically distinct 
genotype groups 1 and 2, and is further classified into subgenotypes 1a, 1b, 2a, and 2b 
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(Ridpath, 2005), among others. In addition to genetic differentiation, the biotype of a 
specific BVDV strain is classified as cytopathic or noncytopathic based upon its ability to 
cause cellular damage in cultured cells (Peterhans et al., 2010). Research would also 
indicate that antigenic differences may exist among BVDV subgenotypes because 
differences in cross-neutralization are observed (Bachofen et al., 2008). Furthermore, 
Burciaga-Robles et al. (2010) observed increased antibody titers to BVDV subgenotype 
1b (strain TGAC 8HB), but not type 1a (Singer strain) or 2a (strain 125-C) when steers 
were exposed to 2 PI-BVDV type 1b challenge animals for 72 h. Ridpath et al. (2010) 
reported that the ratio of virus cross-neutralization among BVDV type 1a and 1b 
subgenotype strains is 36%. These findings identify a critical need for further research 
because currently no commercially licensed modified-live virus (MLV) respiratory 
vaccine in the US contains a BVDV type 1b isolate. Also noteworthy, BVDV type 1b is 
the predominant strain isolated from calves in the US with respiratory disease (Fulton et 
al., 2002). 
 Bovine viral diarrhea virus infection of susceptible cows during the second to 
fourth month of gestation (Peterhans et al., 2010) can result in the birth of a persistently 
infected (PI), immunotolerant calf (McClurkin et al., 1984) that will shed large amounts 
of the noncytopathic biotype of the BVDV subgenotype strain it was exposed to in utero 
throughout its entire lifetime (Kahrs, 2001). There may be a correlation between the 
majority of PI-BVDV calves being infected with BVDV subgenotype 1b (Fulton et al., 
2005), and the fact that this specific BVDV strain is not included in commercial vaccines 
that could provide protection against BVDV emergence in the field. Nevertheless, PI-
BVDV calves may contribute to one of the most critical consequences of BVDV 
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infection, BRD complex, by acting as a primary respiratory pathogen source or through 
immunosuppression of exposed cohorts (Welsh et al., 1995). Although the prevalence of 
PI-BVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al., 
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen 
and adjoining pens to the virus. Moreover, the large population of confined cattle that 
exist for a typical commercial feedlot located in the high-plains region of the US suggests 
that more than 100 PI-BVDV animals may be sporadically located throughout a single 
facility (ie. 50,000 animals × 0.3 prevalence rate = 150 PI-BVDV animals). 
 Some consultants and veterinarians have promoted to stocker or feedlot clientele 
with limited success, testing upon arrival and removal of animals identified as PI-BVDV. 
A significant barrier to more widespread adoption of this practice is the conflicting 
research on effects of PI-BVDV exposure reported in the literature. Nevertheless, several 
commercial and university veterinary diagnostic laboratories offer PI-BVDV testing 
services. The latest, most efficient procedure to determine PI-BVDV status is to test an 
ear-notch tissue sample for the presence of BVDV using the antigen-capture, or 
competitive enzyme-linked immunosorbent assay (ACE) via a commercially available 
test kit (IDEXX HerdChek, IDEXX Laboratories, Westbrook, ME). At the present time, 
the commercial laboratory fee to perform an ACE test ranges from $3.75 to $5.00 per 
sample excluding next day parcel service fees. Because PI-BVDV calves often appear 
otherwise healthy with no visual symptoms of disease, it is impossible to visually identify 
and remove suspected PI-BVDV animals; therefore, a stocker or feedlot producer 
considering this management practice must test an entire population of newly received 
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calves to identify and remove PI calves, representing a significant cost to a producer 
considering this management strategy. 
 Research results on effects of exposure to PI-BVDV calves in the feedlot are both 
limited and conflicting; thus, the decision to invest in PI-BVDV testing and removal of 
PI-positive animals to minimize economic losses associated with BVDV exposure of 
newly received cattle remains controversial. Elam et al. (2008) evaluated the effects of 
long- (duration of study) or short-term (60 h) exposure to a calf identified as PI-BVDV in 
heifers that had been previously vaccinated for BVDV and received antibiotic 
metaphyalxis upon arrival. In this study, no differences in final body weight, dry matter 
intake, feed efficiency, or carcass characteristics were observed with PI-BVDV exposure. 
Furthermore, none of the experimental animals in this study required treatment for BRD, 
indicating that PI-BVDV exposure did not affect BRD morbidity; however, based upon 
the excellent health of experimental animals, physiological stress and 
immunosuppression was probably minimal for heifers in this study. Booker et al. (2008) 
performed a prospective study in 3 Alberta feedlots to observe differences in health and 
performance outcomes of pens with or without a PI-BVDV calf present. Although 
mortality attributed to BVDV was more common in pens containing a PI-BVDV animal, 
no differences in morbidity, overall mortality, ADG, or feed efficiency were observed 
between PI and non-PI pens. Both Elam et al. (2008) and Booker et al. (2008) concluded 
that the presence of a PI-BVDV calf had little or no effect on health or performance, and 
both authors suggested that PI-BVDV exposure may provide enhanced immunity against 
acute BVDV infection. 
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 Loneragan et al. (2005) conducted a cross-sectional study to estimate prevalence 
of PI-BVDV cattle in the feedlot population, prevalence of chronically ill and dead PI-
BVDV cattle, and the effects on BRD morbidity when exposed to a PI-BVDV calf. 
Prevalence of PI-BVDV cattle arriving in the feedlot was 0.3%, and it was reported that 
cattle exposed to a PI-BVDV animal had a 43% greater risk of developing BRD. 
Furthermore, a greater percentage of PI-BVDV animals were present in chronically ill 
(2.6%) and dead (2.5%) cattle. In a study evaluating the effects of PI-BVDV exposure of 
high-risk auction market calves of unknown history (Hessman et al., 2009), cattle directly 
exposed to PI-BVDV challenge had a greater percentage of first relapse, chronic illness, 
and fatalities; however, overall morbidity was not different compared to unexposed 
groups. It was determined through economic analysis that fatalities and performance 
losses due to PI-BVDV exposure accounted for economic losses of $5.26 and 
$88.26/animal, respectively. Furthermore, the authors provided comprehensive 
discussion on susceptibility of PI-BVDV exposure attributing factors of virulence and 
amount of virus particles being shed, frequency of contact, population density, and 
immunocompetence of exposed cohorts as factors that can affect the magnitude of health 
and performance outcome in studies evaluating PI-BVDV exposure. 
 O’Conner et al. (2005) evaluated the association between commingling and PI-
BVDV exposure on feedlot pen morbidity. They reported that disease prevalence was 
least in pens containing single-source cattle with a PI-BVDV calf present, and exposure 
to PI-BVDV in commingled groups also reduced morbidity compared to commingled 
pens with no PI-BVDV calf. Nevertheless, commingling was associated with an increase 
in BRD morbidity. Fulton et al. (2006) suggested that calves previously vaccinated and 
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preconditioned prior to exposure to a PI-BVDV animal can provide protection against 
viremia compared to naïve calves. One inconsistency among PI-BVDV research is the 
use of experimental cattle with varied management and vaccination history, and peer-
reviewed research evaluating effects of PI-BVDV exposure in different BRD risk-groups 
of cattle such as single source, preconditioned versus commingled, auction market calves 
is lacking. 
 Research on the effects of PI-BVDV exposure on APP and cytokine response is 
limited. Burciaga-Robles et al. (2010) examined effects of an intratracheal Manheimia 
haemolytica challenge after 72-h exposure to PI-BVDV subgenotype 1b calves on 
leukocyte and cytokine concentration of feedlot steers. Steers were randomly allocated to 
1 of 4 treatments in a 2 × 2 factorial arrangement: 1) not exposed to PI-BVDV challenge 
nor challenged with M. haemolytica (control), 2) exposed to PI-BVDV challenge for 72 
h, 3) intratracheally challenged with M. haemolytica, and 4) exposed to PI-BVDV 
challenge for 72 h and challenged with M. haemolytica. A main effect of PI-BVDV 
exposure was observed, with PI exposure resulting in reduced numbers of total 
leukocytes, neutrophils, lymphocytes, eosinophils, and basophils. Haptoglobin 
concentrations were not different in steers exposed to PI-BVDV challenge; conversely, 
Ganheim et al. (2003) reported greater haptoglobin concentrations in steers challenged 
intranasally with BVDV type 1. Several pro-inflammatory cytokine levels were impacted 
in the Burciaga-Robles et al. (2010) study. Exposure to PI-BVDV challenge resulted in 
increased IL-1, IL-6, and TNF-α concentrations; whereas, tendencies were noted for IFN-
γ and IL-4. A treatment interaction was observed for IFN-γ, with concentrations being 
greatest for steers exposed to both BVDV and M. haemolytica challenge models, and 
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least for control, BVDV only, and M. haemolytica only challenge. A similar treatment 
interaction was observed for TNF-α, with the greatest serum concentration observed for 
calves exposed to both disease challenge models, suggesting that exposure of naïve 
calves to PI-BVDV challenge increased the potential for secondary infection. 
Conclusions from the Literature 
 Implementation of management (or lack thereof) through the unique segments of 
the beef production system can tremendously impact the health, growth performance, and 
profitability of feeder cattle. As the scientific literature evolves regarding interactions of 
management, physiological stress, and immunosuppression, hopefully adoption of 
management and discovery of new products or methods for mitigation of bovine 
respiratory disease will increase, thereby reducing the industry’s dependence on 
antibiotics to treat bovine respiratory disease. Several biomarkers that may indicate 
physiological stress and disease status, and the continually improving assays to detect 
such biomarkers, hold promise for future research and understanding.  Improved 
understanding of physiological stress and its resulting modulation of immunity and 
disease will have profound effects on the health and well-being of cattle, profitability, 
and ultimately sustainability of the beef industry. 
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ABSTRACT:  Stress commonly associated with weaning, marketing, and shipment of 
feeder cattle can temporarily compromise immune function; thereby, reducing the 
effective response to vaccination intended to control bovine respiratory disease (BRD). 
Two vaccination timing treatments were used to evaluate the effect of timing of a 
multivalent modified live virus (MLV) BRD vaccine on health, performance, and 
infectious bovine rhinotracheitis (IBR) antibody titer level of newly received stocker 
cattle. Crossbred bull and steer calves (n = 528) were weighed (197 ± 2.4 kg) and 
randomly assigned to MLV vaccination treatment: 1) MLV vaccination upon arrival 
(AMLV), or 2) delayed (14 d) MLV vaccination (DMLV). All cattle were processed 
similarly according to routine procedures with the exception of initial MLV vaccination 
timing. Subsequently, BW were recorded on d 14, 28, and 42. Blood samples were 
collected on d 0, 14, 28, and 42 to determine differences in serum IBR titer levels, and 
comparisons were made between treatments on a receiving-day basis and an equivalent 
postvaccination day basis. Daily BW gains were greater (P ≤ 0.05) for DMLV calves 
from d 0 to 14 (1.16 vs. 0.88 ± 0.22 kg/d) and from d 0 to 42 (0.75 vs. 0.65 ± 0.09 kg/d). 
Days to first treatment, total treatment cost, percentage death loss, and pasture ADG after 
the 42-d receiving period did not differ (P ≥ 0.15). Morbidity rates for BRD were high for 
both AMLV and DMLV (71.5 and 63.5%, respectively), and did not differ (P = 0.12). 
Positive IBR titer seroconversion was greater (P ≤ 0.03) for DMLV calves on d 42 of the 
study, and for the 28- and 42-d equivalent postvaccination basis. Delaying vaccination by 
14 d may increase ADG during the receiving period compared with AMLV and 
seroconversion to IBR was greater in DMLV calves, indicating a possible improvement 
in acquired immune response when MLV vaccination is delayed.  
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INTRODUCTION 
 Bovine respiratory disease (BRD) is the most economically important disease in 
newly received beef cattle (Edwards, 1996), and is the leading cause of morbidity and 
mortality according to a recent survey of US feedlots (Woolums et al., 2005). A common 
receiving management strategy includes classification of cattle groups into risk categories 
(high or low risk) for BRD; this is determined by factors including transportation stress, 
immune status, nutritional condition, environment, and the skill level of management 
personnel (Smith, 2004). Calves purchased at local auctions are typically classified as 
high risk for developing symptoms of BRD because theses cattle are of unknown origin, 
commingled, and recently weaned from small cow-calf operations that seldom use 
vaccination or other BRD prevention strategies (National Animal Health Monitoring 
System, 1997). Stress and previous exposure to BRD pathogens may decrease vaccine 
efficacy (Blecha et al., 1984; Loerch and Fluharty, 1999). The transportation stress period 
can endure for as long as 15 d after arrival, based on serum hemolytic complement 
concentration of calves (Purdy et al., 2000). Perino and Hunsaker (1997) indicated that 
BRD vaccination on arrival at feedlots is equivocal at best. Other complications with on-
arrival administration of a modified live virus (MLV) vaccine may include reduced gain 
performance caused by immunological challenges from antigens contained in a vaccine; 
however, Stokka and Edwards (1990) reported no detrimental effects on gain of stressed 
calves receiving a multiple polyvalent MLV vaccine. Current feedlot receiving protocols 
include multivalent vaccination against BRD viruses within 48 h of arrival for high-risk 
cattle, although the vaccine response and health benefit are questionable.  
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 Thus, our objective was to evaluate the effect of delayed (14 d) MLV vaccination 
vs. on-arrival MLV vaccination on health, performance and serum infectious bovine 
rhinotracheitis (IBR) titer levels of newly received high-risk stocker calves. 
MATERIALS AND METHODS 
 Animal methods were approved by the University of Arkansas Animal Care and 
Use Committee.  
 A total of 528 crossbred bull (n = 364) and steer (n = 164) calves (initial BW = 
197 ± 2.4 kg) were purchased from a northern Arkansas auction barn and shipped 
approximately 9 km to the University of Arkansas, Livestock and Forestry Branch 
Station, near Batesville, AR. Cattle were received on 6 dates: September 9, 2004 (Block 
1, n = 110), September 16, 2004 (Block 2, n = 98), January 10, 2005 (block 3, n = 80) 
January 13, 2005 (Block 4, n = 80), February 14, 2005 (block 5, n = 70), and February 
17, 2005 (Block 6, n = 90). Pen was designated as the experimental unit. For each date 
block, 6 pens (3 treatments/pen) were used; therefore, each treatment was replicated a 
total of 18 times. Because the number of animals per block varied, the number of animals 
per pen ranged from 10 to 19, but within each block the number of animals assigned to 
each treatment were equivalent. 
 Upon arrival (d -1), cattle were weighed (unshrunk), assigned a unique ear 
identification tag, and arrival castrate status (bull or steer) was determined. Calves 
remained commingled overnight, with access to hay and water. The following day (d 0), 
bulls and steers were assigned to treatment based on castrate status, which was equally 
distributed to treatments by assigning a similar number of bull and steer calves to each 
treatment pen, with pens then assigned to treatment. Treatments included 1) initial 
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vaccination of a multivalent BRD MLV on arrival (d 0; AMLV), or 2) 14-d delayed 
initial vaccination of the BRD MLV (DMLV). On d 0, calves were reweighed, 
administered a clostridial bacterin with tetanus toxoid (Covexin-8; Schering-Plough 
Animal Health, Inc., Elkhorn, NE), treated for internal and external parasites (Ivomec; 
Merial, Iselin, NJ) and bull calves were castrated using the California banding method 
(InoSol Co. LLC, El Centro, CA). Calves were administered 2 injections of a MLV BRD 
vaccine 14 d apart. Arrival MLV calves were vaccinated with a 5-way MLV vaccine 
containing isolates of IBR, bovine virus diarrhea (BVD) types I and II, bovine respiratory 
syncytial virus (BRSV), and parainfluenza (PI3) in combination (Express 5; Boehringer-
Ingelheim Vetmedica, Inc., St. Joseph, MO), whereas cattle assigned to the DMLV 
treatment did not receive their initial 5-way MLV vaccination until d 14 of study. 
 In addition, the rectal temperature of each calf was determined using a digital 
thermometer (Model No. M216, GLA Agricultural Electronics, San Luis Obispo, CA). 
Calves with rectal temperatures of ≥40°C during the initial processing were administered 
prophylactic treatment with tilmicosin phosphate (10mg/kg of BW, Micotil, Elanco 
Animal Health, Indianapolis, IN) as described by Galyean et al. (1995). The percentage 
of animals administered antibiotic on arrival (AMLV = 18.6%; DMLV = 23.4%) was not 
different (P = 0.19), and these calves were excluded from subsequent morbidity analysis. 
After cattle were randomly sorted, they were moved to 0.4-ha pens separated by 
electrified fencing and provided a 16% CP supplement at 1% of BW (DM basis) and 
free-choice access to Bermudagrass hay (10% CP, 56% TDN) for the entire 42-d 
receiving study. The receiving supplement contained (as-fed basis) 67% corn, 19% 
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cottonseed meal, 12.5% corn gluten feed, 1.5% limestone, and 0.04% Rumensin 80 
(Elanco Animal Health) and supplied 368 g of CP and 200 mg of monensin/d. 
 To determine differences in BW gain performance, cattle were weighed (un-
shrunk) at 14-d intervals during the trial (d 14, 28, and 42). On d 14, both AMLV and 
DMLV cattle received a booster vaccination of the clostridial bacterin with tetanus toxoid 
(Covexin-8), AMLV cattle received a booster vaccination of the 5-way MLV (Express 5), 
and DMLV cattle received their initial dosage of 5-way MLV (Express 5). Two weeks 
later (d 28), DMLV cattle received their respective booster vaccination of 5-way MLV 
(Express 5). At the conclusion of the 56-d receiving period, calves were implanted with 
40 mg of trenbolone acetate and 8 mg of estradiol (Revalor G, Intervet Inc., Desoto, KS) 
and the pasture phase of the study began. 
 Calves were observed each morning (0800 h) by Livestock and Forestry Branch 
Station personnel for symptoms of respiratory illness (depression, lethargy, rapid 
breathing, nasal or ocular discharge), slowness in going to the feedbunk when supplement 
was provided, and a gaunt or emaciated appearance. Personnel were blinded to the 
treatment allotment of each pen. Cattle with observed visual symptoms of BRD were 
removed, restrained using a hydraulic squeeze chute (Flying W Inc., Watonga, OK) and 
considered morbid if their rectal temperature was ≥40°C. Morbid animals from both 
treatments were administered antibiotic therapy following the same predetermined 
antibiotic treatment protocol which included initial antibiotic therapy with tilmicosin 
phosphate (Micotil, 10 mg/kg of BW). Cattle were reevaluated 72 h later, and those with 
a rectal temperature of ≥40°C were considered morbid a second time and administered a 
second antibiotic treatment with enroflaxacin (Baytril, Bayer Animal Health, Shawnee 
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Mission, KS). After reevaluation, cattle requiring treatment a third time were 
administered florfenicol (Nuflor, Schering-Plough Animal Health, Summit, NJ). After 3 
treatment events, cattle were considered non-responsive and no further antibiotic therapy 
was administered regardless of the symptoms. Cattle were returned to their respective 
home pen immediately following each antibiotic treatment. Treatment data recorded for 
individual animals included the treatment date and the amount, type and cost of antibiotic 
administered. 
 Blood samples were collected from 3 randomly selected animals in each pen to 
evaluate serum IBR titer levels. Blood was collected via jugular venipuncture from the 
same animals on d 0, 14, 28, and 42 for AMLV and d 0, 28, 42, and 56 for DMLV and 
stored in 15-mL Vacutainer tubes (BD Inc., Franklin Lakes, NJ). Blood was placed in a 
refrigerator at 4°C for 6 h after collection, and serum was separated by centrifugation at 
1,000 × g for 30 min. Serum was then decanted and stored at -5°C for subsequent 
analysis, when all samples from the entire study were compiled. Once all serum samples 
were collected, they were packaged and shipped overnight to the diagnostic laboratory 
(Oklahoma Animal Disease Diagnostic Center, Stillwater, OK) for assay of IBR virus 
antibodies by the serum neutralization method, as described by Rosenbaum et al. (1970). 
Titers were reported as the reciprocal of the greatest dilution of serum that provided 
complete protection of the cells. The lowest dilution of serum tested was 1:4, whereas the 
greatest dilution of serum tested was 1:256. Serum that did not provide protection at the 
1:4 level were reported as <4, and was considered negative for seroconversion to IBR. 
Samples with a reported serum neutralization value of 4 were considered positive for 
seroconversion to IBR. Titers were evaluated to determine differences in the percentage 
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of animals in each treatment with positive seroconversion to IBR. According to 
laboratory results (Oklahoma Animal Disease Diagnostic Center), samples with a 
reported serum neutralization value of <4 were considered negative and those 4 were 
considered positive for IBR seroconversion. Titers <4 were assigned a value of 0, whereas 
titers 4 were assigned a value of 1 and analyzed by 2 analysis to determine the 
percentage positive for differences in treatment by day. Percentage of IBR seroconversion 
was compared on both a receiving-day basis and a vaccination timing-equivalent basis. 
Receiving-day IBR titer comparisons were made from samples collected on d 0, 28, and 
42. Vaccination timing-equivalent comparisons were made for IBR titers based on the 
number of days postinitial vaccination (d 0 AMLV vs. d 14 DMLV) and postbooster 
vaccination (d 14 AMLV vs. d 28 DMLV). Therefore, a blood sample was collected from 
DMLV calves after the receiving period had ended (d 56) to allow a final vaccine timing-
equivalent comparison (d 42 AMLV vs. d 56 DMLV). 
Statistical Analysis  
Treatment data were analyzed as a randomized complete block design. Pen was identified 
as the experimental unit. Date of shipment arrival was treated as the random block effect 
in the model. The treatment x block interaction was used as the denominator mean square 
for the treatment effect test. Gain performance data, days to first pull, and treatment cost 
were analyzed using PROC MIXED (SAS Inst. Inc., Cary, NC). Initial BW was used as a 
covariate, and arrival castrate status (steer vs. bull) was used as a source of variation in 
the model to minimize the unwanted effects of arrival BW and castrate status on 
treatment outcome. 
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RESULTS AND DISCUSSION 
Performance and Health  
 Body weight and ADG during receiving and grazing are presented in Table 1. 
Body weight of calves in the DMLV treatment was greater (P = 0.007) on d 14 and 
tended to be greater (P = 0.07) on d 42 than those in the AMLV treatment. Average daily 
gain was greater (P = 0.007) for DMLV cattle compared with AMLV from d 0 to 14 of 
the study (1.16 vs. 0.88 ± 0.22 kg/d). For the first 14 d of the study, AMLV had been 
administered an MLV vaccine, whereas DMLV had not yet received an initial MLV 
vaccine and could be considered a negative control. The difference in gain performance 
remained for the overall 42-d receiving period, with AMLV averaging 0.65 vs. 0.75 (± 
0.09) kg/d for DMLV (P = 0.05). Average daily gain from d 14 to 28 was not different (P 
= 0.45). The performance reduction in AMLV cattle from d 0 to 14, and in DMLV cattle 
from d 14 to 28, suggests that the initial physiological response to an MLV vaccine may 
elicit consequences that are temporarily detrimental to growth performance. No 
differences (P = 0.15) were detected for pasture ADG during the subsequent grazing 
period. 
 Mass antibiotic metaphylaxis was not used in the current study; however, cattle 
were given prophylactic antibiotic treatment on arrival if the rectal temperature was 
40.0°C. Galyean et al. (1995) reported that regardless of whether newly received calves 
were mass medicated with tilmicosin or received tilmicosin when the rectal temperature 
was 39.7°C, there was a similar reduction in percentage of calves treated for BRD 
compared with control calves. Based on our protocol, a similar (P = 0.19) number of 
animals for AMLV (18.6%) and DMLV (23.4%) qualified for on-arrival antibiotic 
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treatment, and there was no difference (P = 0.83) in rectal temperature on arrival 
(averaging 39.6°C; Table 2). Of the calves included in the morbidity analysis, 90.0% of 
initial BRD treatment episodes for AMLV and 88.8% of treatment episodes for DMLV 
had occurred by d 14 of the study (Figure 1). There were no differences (P 0.16) in the 
number of days to first treatment, mortality, or treatment cost for morbidity. The initial 
treatment rate for BRD was high (AMLV = 71.5%, DMLV = 63.5%) but not different (P 
= 0.12; Table 2). The high rate of BRD morbidity is not uncommon in calves purchased at 
local auction barns and received at the Livestock and Forestry Branch Station. In this 
study, on-arrival MLV vaccination did not seem to be advantageous for either gain 
performance or disease prevention based on our results. 
 Duff et al. (2000) used 2 studies to evaluate the effects of viral vaccine route of 
administration and vaccine timing on the health and performance of newly received beef 
cattle. In the first study, ADG was greater for calves receiving an intranasal vaccine 
compared with an i.m. MLV IBR-PI3 vaccine but was not greater than for unvaccinated 
control calves, yet the rate of morbidity did not differ. In the second study, Duff et al. 
(2000) reported no differences in BW gain among nonvaccinated calves, calves with 4-
way MLV vaccination delayed until d 7, calves that received an intranasal IBR-PI3 
vaccine administered on d 0 with 4-way MLV vaccination delayed until d 7, or calves that 
received a 4-way MLV vaccination on both d 0 and 7. However, G:F tended to be 
improved for vaccinated calves vs. nonvaccinated calves. Kreikemeier et al. (1996b) 
found that during the initial 21 d of the feedlot receiving period, calves vaccinated with a 
killed virus on the farm before weaning and revaccinated with a killed virus at the time of 
commingling at a sale barn tended to gain faster than calves given an MLV upon arrival 
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at the feedyard and revaccinated 21 d after feedyard arrival. Preweaning BRD vaccination 
is certainly preferable; however, newly received calves of unknown origin that are 
allowed a period to adjust to their new environment and recover from previous stressors 
may be better suited to respond to MLV vaccination. Kreikemeier et al. (1996a) used a 2 
× 2 factorial arrangement of treatments, which included mass medication with either 
tilmicosin phosphate or chlortetracycline or no mass medication, and routine processing 
on either d 1 or 21. Processing included a growth implant, an 8-way clostridial vaccine, a 
4-way MLV vaccine, and an injectable dewormer. For the entire 56-d receiving period, 
calves that received processing on d 1 gained faster than calves with processing delayed 
until d 21. This is inconsistent with our results of increased ADG for DMLV; however, 
their study also included delayed administration of a growth implant and dewormer for 21 
d, which could explain the difference in results.  
 No differences were detected (P > 0.11) for the effects of MLV vaccination 
timing on initial treatment for BRD-associated morbidity, percentage of calves retreated 
for BRD, mortality, or treatment cost (Table 2). The overall consensus among animal 
health professionals and veterinarians seems to support arrival vaccination against BRD 
as an effective method of disease prevention, and a study by Hansen et al. (1992) supports 
this view when the morbidity rate is high. However, several groups have reported a 
neutral outcome when vaccinating newly received beef cattle for BRD (Bateman, 1988; 
Johnson et al., 1988; Duff et al., 2000). Martin et al. (1982) reported an increased risk of 
mortality when a respiratory vaccine was administered within 14 d of arrival. In that 
study, delaying the BRD vaccination in calves for 14 d from arrival decreased the 
mortality and treatment cost in cattle fed corn silage-based diets; however, no vaccination 
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timing differences were noted when cattle were fed dry hay-based diets. In the current 
study, the initial morbidity rate for BRD was high for both AMLV and DMLV (71.5 and 
63.5%, respectively) but did not differ between treatments (P = 0.12). Overall, 93% of 
BRD pulls occurred within the first 14 d of receiving (Figure 1). These data suggest little 
or no advantage of administering a 5-way MLV vaccine to high-risk stocker cattle on 
arrival. The high morbidity rate (Figure 1) observed before d 14 indicates that few 
changes in the receiving protocol could have affected morbidity rates.  
IBR Titers 
 Serum titers are used as an indication of antibody protection against a specific 
pathogen, thereby providing an indication of vaccine efficacy (Callan, 2001). It is poorly 
understood how acquired antibody levels may be affected by the timing of vaccination 
before or during the receiving period; however, stress is known to compromise immune 
function (Chirase et al., 2004), and label guidelines according to the vaccine 
manufacturers recommend that vaccination of stressed cattle be avoided.  
No differences (P = 0.94) were detected for the percentage of positive IBR titers on d 0 
(Figure 2), and positive seroconversion was low (AMLV = 8.8%; DMLV = 8.4%). On the 
basis of the vaccination timing-equivalent comparison, DMLV resulted in a greater 
percentage (P 0.03) of animals seropositive to IBR 28 and 42 d after the initial 
vaccination (Figure 2). When treatments were compared at the conclusion of the 
receiving period (d 42) the DMLV treatment exhibited greater (P = 0.01) IBR virus 
antibody titer seroconversion. Results of IBR titer level comparisons suggest an improved 
vaccine response for DMLV. Natural disease exposure and subsequent host immune 
response may have contributed to the increased IBR antibody titers in this study; 
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however, the extent to which natural exposure affected IBR seroconversion is unknown. 
No difference in arrival (d 0) IBR titer levels were detected (P 0.95) in animals that 
became morbid once or twice compared with those never treated during the study (data 
not shown). Martin et al. (1999) reported seroconversion of BRSV and BVD viruses from 
d 0 to 28 in unvaccinated animals; however, mean IBR titers were low and were not 
different on either d 0 or 28 in unvaccinated calves both treated for BRD and not treated. 
Measurement of neutralizing antibody titers has been reported to provide an indication of 
the amount of BVD protection present in calves (Bolin and Ridpath, 1995) and has been 
positively correlated with disease prevention (Howard et al., 1989). This has not been 
studied as extensively in IBR; thus, further research on the role IBR titers may relate to 
BRD protection in the field is warranted. 
 Delaying initial MLV vaccination by 14 d improved the gain performance of 
high-risk, newly received cattle during the receiving period compared with MLV 
vaccination on d 0. Morbidity rate or cost associated with BRD was not different. 
Moreover, serum IBR titers were greater when initial MLV vaccination was delayed. 
Because no differences in morbidity or mortality were detected for the 2 treatments, and 
performance for DMLV cattle was slightly improved, results of the current study suggest 
an economic advantage to delaying initial MLV vaccination until 14 d after arrival. 
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Table 1. Effect of BRD vaccination timing on performance of newly received cattle. 
 On Arrivala Delayeda SEb P-Value 
BW, kg d     
  Day 0 197.7 195.9 2.42 0.33 
  Day 14 208.6 212.7 3.03 0.007 
  Day 28 217.4 219.9 2.93 0.16 
  Day 42 224.4 228.1 4.08 0.07 
ADG, kg/d c     
  D 0 to 14 0.88 1.16 0.22 0.007 
  D 14 to 28 0.61 0.53 0.15 0.45 
  D 28 to 42 0.45 0.56 0.10 0.12 
  D 0 to 42 0.65 0.75 0.09 0.05 
Pasture ADG, kgd 0.89 0.84 0.08 0.15 
aTreatments were vaccination of incoming stocker cattle with Express® 5 (Boehringer 
Ingelheim) modified live IBR, PI3, BRSV and BVD type I and II vaccine either on 
arrival at initial processing (d-0) or on d-14. Cattle were re-vaccinated 14 d following 
initial vaccination. 
bStandard Error of the mean (n = 524). 
cAll analysis (except d-0 BW) was conducted using BW and gender on d-0 as a covariate. 
dGrazing performance calculated subsequent to the 42 d receiving period. 
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Table 2. Effect of BRD vaccination timing on morbidity, mortality and treatment 
cost of newly received cattle. 
 On Arrivala Delayeda SEb P-Value 
Rectal Temperature on d-0, C 39.61 39.56 0.23 0.83 
BRD Treatment, %     
Initialc 75.3 70.2 0.10 0.21 
Re-treatd 29.4 35.1 0.11 0.08 
Days to 1st treatment 5.7 5.1 1.10 0.44 
Death loss, % 2.3 0.8 0.75 0.19 
BRD Treatment Cost, $e 10.29 10.64 2.36 0.75 
aTreatments were vaccination of incoming stocker cattle with Express® 5 (Boehringer-
Ingelheim) modified live IBR, PI3, BRSV and BVD type I and II vaccine either on 
arrival at initial processing (d-0) or on d-14. Cattle were re-vaccinated 14 d following 
initial vaccination. 
bStandard Error of the mean (n = 524). 
cInitial, cattle with observed symptoms of BRD and temperature in excess of 40° C were 
injected with Micotil (Elanco) at 1.5 cc/ 45.5 kg BW. 
dRe-treat, 72 h following initial, cattle with observed symptoms of BRD and temperature 
in excess of 40° C were injected with Baytril (Bayer) at 4.0 cc/ 45.5 kg BW. 
eTreatment cost for BRD assuming value of Micotil $1.10/cc and Baytril $0.53/cc. 
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ABSTRACT: Stress, commonly associated with weaning, marketing, and shipment of 
feeder cattle can compromise immune function, and vaccine administration during 
immunosuppression may reduce vaccine efficacy and calf growth. Four treatments were 
compared in a 2  2 factorial arrangement to evaluate the effect of on-arrival (d 0) vs. 
delayed (d 14) administration of clostridial (CLOS) and respiratory (RESP) vaccines on 
health, performance, bovine viral diarrhea virus (BVDV) antibody titers, and 
physiological immune measurements of high-risk, newly received calves. Crossbred bull 
and steer calves (n = 263) were weighed (239 ± 1.2 kg), stratified by gender, and 
randomly assigned to vaccination treatment: 1) arrival CLOS, arrival RESP (ACAR); 2) 
arrival CLOS, delayed RESP (ACDR); 3) delayed CLOS, arrival RESP (DCAR); and 4) 
delayed CLOS, delayed RESP (DCDR). Body weight and blood samples were collected 
on d 0, 14, 28, 42, and 56. Average daily gain did not differ (P ≥ 0.34) averaging 0.98, 
0.93, 0.95, and 0.91 kg/d for ACAR, ACDR, DCAR and DCDR, respectively, for the 
entire 56 d trial. Vaccination timing did not affect morbidity (P ≥ 0.23); however, there 
tended to be a CLOS timing effect (P = 0.07) and RESP timing effect (P = 0.09) on d to 
initial bovine respiratory disease (BRD) treatment. Average d to initial BRD treatment 
were less for ACAR (6 ± 0.8 d) compared to DCDR (8 ± 0.8 d; P = 0.01). Greater white 
blood cell (WBC) counts were observed for DCDR than ACDR (P = 0.01), with ACAR 
and DCAR being intermediate. Serum cortisol concentrations were greater on d 0 than d 
14 (P < 0.01) or d 28 (P = 0.01) but no treatment  day interaction (P = 0.21) was 
observed. Timing of RESP administration affected (P = 0.001) serum BVDV type I titer 
levels, with greater (P < 0.01) levels in calves receiving RESP vaccine on arrival.  
Delaying CLOS or RESP vaccination did not affect gain or morbidity in high risk, newly 
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received stocker calves. Calves administered RESP vaccine on d 0 developed antibody 
titers to BVDV type I earlier than delayed RESP treatments. Total WBC count was 
greatest when RESP and CLOS vaccination were delayed (DCDR). 
INTRODUCTION 
 Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality 
according to a recent survey of US feedlots (Woolums et al., 2005), resulting in 
significant economic losses to the beef cattle industry.  Calves purchased at local auction 
markets throughout the southeastern US are typically classified as high-risk for 
developing signs of BRD because these cattle are of unknown origin and recently weaned 
from small cow-calf operations that seldom utilize vaccination or other BRD prevention 
strategies (NAHMS, 1997). These high-risk cattle may be suffering stress effects 
resulting from a combination of commingling, transport, nutritional, weaning and 
environmental stressors that can compromise the immune system (Smith, 2004), and the 
transportation stress period can endure for as long as 15 d post-arrival based on serum 
hemolytic complement concentration (Purdy et al., 2000). Vaccination against viral 
and/or bacterial pathogens that contribute to BRD can be an effective preventative 
strategy; however, vaccine efficacy may be reduced if administered during 
immunosuppression (Callan, 2001), and a review of field vaccine efficacy by Perino and 
Hunsaker (1997) suggested that administering BRD vaccination at arrival in North 
American feedlots was generally not supported by published research. Other 
complications with on-arrival vaccination may include reduced gain performance 
(Chirase et al., 2001; Richeson et al., 2008), perhaps due to immunological challenge 
from vaccine antigens during a period when calves may be experiencing stress-induced 
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immunosuppression. Thus, our objective was to evaluate the effect of delaying 
respiratory and/or clostridial vaccination (d 14 vs. arrival) on health, performance, serum 
bovine viral diarrhea virus (BVDV) type I titers, and physiological stress and immune 
measures in high-risk, newly received calves. 
MATERIALS AND METHODS 
 Animal methods were approved by the University of Arkansas (UA) Animal Care 
and Use Committee.  
 Crossbred bull (n = 207) and steer (n = 57) calves (BW = 239 ± 1.2 kg) were 
procured by an order buyer from multiple auction markets located in western Arkansas 
and eastern Oklahoma and shipped to the UA Agricultural Experiment Station located 
near Savoy. These calves were likely commingled extensively from numerous herds and 
were experiencing other stressors described by Smith (2004) and thus would be 
considered high-risk for BRD. Three separate shipment dates representing each block in 
the experimental model were received on February 12 (Block 1, n = 90), March 1 (Block 
2, n = 91), and April 17, 2007 (Block 3, n = 83). Calves in each block were divided into 8 
pens (10 to 12 calves/pen); thus, each of the 4 treatments were replicated 6 times. 
 Upon arrival, cattle within each block were weighed, assigned a unique ear 
identification tag and gender was determined (bull or steer). Within gender (bull or steer), 
calves were randomly distributed to 1 of 8 pens. The 8 pens had been randomly assigned 
to 1 of 4 vaccination-timing treatments (Table 1). Treatments were arranged as a 2  2 
factorial with Clostridium chauvoei, septicum, novyi, and sordellii and perfringens types 
C & D bacterin-toxoid in a special oil adjuvant (Alpha 7, Boehringer Ingelheim 
Vetmedica, St. Joseph, MO; CLOS) and infectious bovine rhinotracheitis, bovine viral 
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diarrhea virus type 1a (Singer strain) and type 2a (Bolin 296 strain), parainfluenza3, and 
bovine respirtatory syncytial virus modified-live virus vaccine (Express 5, Boehringer 
Ingelheim Vetmedica, St. Joseph, MO; RESP) administered either on arrival (d 0) or 
delayed (d 14). This resulted in the 4 treatments: 1) arrival CLOS and RESP (ACAR), 2) 
arrival CLOS and delayed RESP (ACDR), 3) delayed CLOS, and arrival RESP (DCAR), 
and 4) delayed CLOS and  RESP (DCDR). Treatments were not arranged spatially 
according to vaccination treatment; because of random treatment assignment there were 
instances where vaccinated and non-vaccinated calves had fence-line contact during the 
study. However, using the same RESP vaccine as in the current study, Kleiboeker et al. 
(2003) concluded that shedding of BVDV type I or II in calves after vaccination was 
either nonexistent or undetected and did not result in transmission of either BVDV 
genotype in pregnant contact control cows.    
 In addition to receiving their assigned vaccination treatment on d 0, calves were 
treated for internal and external parasites (Cydectin, Fort Dodge Animal Health, Fort 
Dodge, IA), branded, administered metaphylactic antibiotic treatment with tilmicosin 
(Micotil, Elanco Animal Health, Indianapolis, IN) according to BW, and bull calves were 
surgically castrated. An ear notch sample was collected from each animal to test for 
persistently infected BVDV (Cattle Stats, Oklahoma City, OK). One animal in Block 1 
was identified as such and was removed from the study pen and quarantined on d 3. 
Furthermore on d 0, blood samples from 5 randomly selected animals in each pen were 
drawn intravenously from a jugular vein into untreated vacuum tubes (Vacutainer, BD 
Inc., Franklin Lakes, NJ) for subsequent analysis of serum cortisol concentrations and 
BVDV type I titer levels (plain tube). A second blood sample (10 mL) was collected into 
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vacuum tubes containing EDTA (BD, Inc.) for determination of white blood cell (WBC) 
total and differential counts. Cattle were then moved to their assigned 0.45-ha pens and 
provided 0.9 kg/calf (as-fed basis) of a receiving supplement (20.6% CP, DM basis; 
Table 2) and free-choice access to bermudagrass hay (14.5% CP, 33.6% ADF, 68.3% 
NDF, and 7.9% ash, DM basis). Supplement was offered daily at 0800 h and increased to 
a maximum of 1.8 kg/calf daily as calves began consuming the supplement. 
 A booster vaccination of RESP was administered 14 d following initial RESP 
vaccination according to treatment protocol (Table 1). Cattle were re-weighed, unshrunk, 
before offering supplement at 14-d intervals during the trial (d 14, 28, 42, and 56) to 
determine interim and overall differences in BW gain performance. The same 5 animals 
per pen selected for blood collection upon arrival were similarly sampled on d 14, 28, 42, 
and 56.  
 Blood in the plain tubes was centrifuged at 2,100  g for 20 min at 20°C, and 
serum was stored frozen at -20°C until analyzed. Serum cortisol concentrations were used 
as an indication of overall physiological stress and were determined using commercially 
available RIA kits (Coat-A-Count, DPC, Los Angeles, CA) with an intra- and inter-assay 
CV of 1.04 and 23.0%, respectively. Sensitivity of the assay was 0.2 μg/100 mL. The use 
of this assay has been previously validated (Godfrey et al., 1991). Frozen serum samples 
were shipped on ice via overnight parcel service to the Oklahoma Animal Disease 
Diagnostic Laboratory (Stillwater) for determination of serum neutralizing antibodies for 
BVDV type I. Whole blood collected in tubes containing EDTA was kept refrigerated 
and used within 24 h to determine concentrations (n cells/µL) of total WBC, 
concentrations and percentages of differential WBC (lymphocytes, neutrophils, 
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monocytes, eosinophils, and basophils), total red blood cells, hemoglobin, hematocrit, 
and platelets with an automated hematology analyzer (Cell-Dyn 3500 system, Abbott 
Laboratories, Abbot Park, IL) standardized for analysis of bovine blood. 
 After arrival metaphylaxis with tilmicosin (Micotil, Elanco Animal Health, 
Indianapolis, IN), a 48 h post-treatment interval (PTI) was implemented; therefore, calves 
were observed each morning beginning on d 3 of the study for clinical signs of 
respiratory illness by 2 experiment station personnel having a combined 20-yr experience 
evaluating cattle with BRD. These personnel were present during processing and were 
not blinded to treatment; however, no records left at the facility identified treatment 
assignments. Signs used to identify respiratory illness included depression, nasal and 
ocular discharge, cough, increased respiratory rate and poor appetite. Cattle with 2 or 
more visual signs of BRD were pulled and considered morbid if rectal temperature was ≥ 
40°C. Morbid animals were given antibiotic therapy following a pre-determined 
antibiotic treatment protocol and returned to the home pen. A re-check temperature was 
taken 48 h following initial treatment with florfenicol (Nuflor, Schering-Plough Animal 
Health, Summit, NJ). If the re-check temperature was ≥ 40°C, a second antibiotic 
treatment with ceftiofur crystalline free acid (Excede, Pfizer Animal Health, New York, 
NY) was administered. A 72 h PTI was implemented for cattle administered ceftiofur 
crystalline free acid and rectal temperature was re-evaluated. If the re-check temperature 
was ≥ 40°C, a third and final antibiotic treatment with danofloxacin mesylate (A180, 
Pfizer Animal Health) was administered and repeated 48 h following the first injection. 
Cattle that continued to display BRD symptoms after the third treatment were considered 
chronically ill and no further antibiotic treatment was administered.  If at any time a re-
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check temperature was < 40°C, the animal was left untreated unless further symptoms 
developed. Treatment data recorded for individual animal included treatment date, rectal 
temperature, and the amount and type of antibiotic administered. 
 Titers were evaluated to determine differences in the concentration of BVDV type 
I antibodies and the percentage of animals in each treatment with positive seroconversion 
to BVDV type I using the serum neutralization method as described by Rosenbaum et al. 
(1970). Titers were reported as the reciprocal of the greatest dilution of serum to provide 
complete protection of cells. The lowest dilution of serum tested was 1:4; whereas, the 
greatest dilution tested was 1:256. Serum that did not provide protection at the 1:4 level 
was reported as < 4, and was considered negative for seroconversion to BVDV. Samples 
with a reported serum neutralization value of ≥ 4 were considered positive for 
seroconversion to BVDV. For the titer level analysis, the reported values were log2 
transformed and statistically evaluated. To analyze for percentage seroconversion to 
BVDV type I, titer values < 4 were assigned 0 (negative); whereas, titers ≥ 4 were 
assigned a value of 1 (positive). Receiving-day BVDV titer comparisons were made from 
samples collected on d 0, 14, 28, and 42. Vaccination timing-equivalent comparisons 
were made for BVDV titers based on the number of d post-initial RESP vaccination (d 0 
ACAR, DCAR vs. d 14 ACDR, DCDR) and post-booster vaccination (d 14 ACAR, 
DCAR vs. d 28 ACDR, DCDR). 
Statistical Analysis 
 Performance and morbidity data were analyzed as a randomized complete block 
design using the PROC MIXED procedure of SAS (SAS Inst., Inc., Cary, N.C.). Pen was 
considered the experimental unit. The class statement included block (date of arrival), 
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treatment, and replicate. Block and block  replicate  treatment were treated as random 
effects in the model. Single degree of freedom orthogonal contrasts evaluating effects of 
CLOS timing, RESP timing, and the interaction were used. If the interaction was 
significant (P ≤ 0.10), treatment means were separated with a t-test using the PDIFF 
option in SAS. Cortisol, total and differential WBC, total red blood cell, hemoglobin, 
hematocrit, platelets and BVDV type I titer data were analyzed using the PROC MIXED 
procedure with repeated measures. Pen was considered the experimental unit for these 
data. The model included treatment, day and treatment  day. Block, replicate, treatment, 
and day were used in the class statement. Block was the random variable, and the 
repeated statement was day with block  treatment within replicate as the subject. The 
covariance model structure used was AR(1). Contrasts for the repeated measures data 
included CLOS timing, RESP timing, their interaction, and linear, quadratic, cubic, and 
for some variables quartic effects of day. 
RESULTS AND DISCUSSION 
Performance 
 No differences (P ≥ 0.34) in ADG were observed during the 56 d receiving period 
(Table 3). Experiments involving vaccination timing of newly received calves are 
conflicting. In one trial (Richeson et al., 2008), calves that received delayed (14 d) 
vaccination of a modified-live virus (MLV) respiratory vaccine (Express® 5) had greater 
ADG. Kreikemeier et al. (1996) observed that during the initial 21 d of the feedlot 
receiving period, calves vaccinated for BRD with a killed-virus at the farm prior to 
weaning and re-vaccinated with a killed virus at the time of commingling at a salebarn 
tended to gain faster than calves given a MLV upon arrival at the feedyard and 
 61 
revaccinated 21 d after feedyard arrival. Conversely, Duff et al. (2000) reported no 
differences in BW gain among 4 vaccination treatments, including 1) no vaccine 
(control); 2) delayed 4-way [infectious bovine rhinotracheitis (IBR), BVDV, 
parainfluenza3 (PI3), bovine respiratory syncytical virus] MLV vaccination until d 7; 3) 
intranasal IBR-PI3 administered on d 0 with delayed 4-way MLV vaccination until d 7; 
and 4) 4-way MLV vaccination on both d 0 and d 7. Clostridial vaccines contain a special 
and often proprietary adjuvant used to enhance the immune response to the killed 
antigens contained in the vaccine; however, the effect of different adjuvants on animal 
performance deserves consideration. Chirase et al. (2001) conducted 2 experiments to 
evaluate the effects of clostridial vaccines and injection site on performance. In Exp. 1, 
calves given an injection of saline subcutaneously prescapula (control) had greater (P < 
0.01) ADG than calves injected s.c. prescapula with Vision 7 (7-way clostridial, Intervet 
Inc. Millsboro, DE) or Ultra 7 (7-way clostridial, Pfizer Animal Health) but not Alpha 7 
injected subcutaneously either prescapula or in the ear, which is the clostridial vaccine 
used in the current study. Spurlock (1997) reported that repeated immune stimulation can 
result in decreased growth of an animal because nutrients are preferentially utilized for 
immune and homeostatic pathways. Conflicting results of vaccination on receiving cattle 
performance may be due to a number of host factors such as vitamin/mineral status, 
vaccination history, and the stress level of a particular group. Further research is needed 
to evaluate the effects of vaccination on animal performance during the receiving period. 
Health 
 The majority of the cattle became sick with 69% of all calves being treated at 
least one time for BRD (Table 4), but morbidity rates were not different among 
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treatments (P ≥ 0.23). Likewise, no differences were observed in the number of 2nd (P ≥ 
0.18) or 3rd (P ≥ 0.37) BRD treatments. Combined death loss (1.9%) did not differ (P ≥ 
0.64) among treatments. There was a vaccine type × timing interaction (P = 0.05) for the 
percentage of chronic animals, ACDR had a greater percentage of chronic animals than 
ACAR (P = 0.04) and DCDR (P = 0.08), but not DCAR (P = 0.26). 
There was a tendency for CLOS (P = 0.07) and RESP (P = 0.09) timing effects on 
days to initial BRD treatment. Days to initial BRD treatment were fewer (P = 0.01) for 
ACAR (6 ± 0.76 d) than DCDR (8 ± 0.76 d). This difference may be a result of additive 
effects of on-arrival vaccination on the visual symptoms of BRD in cattle receiving both 
CLOS and RESP on d 0 (ACAR) vs. cattle receiving no vaccine until d 14 (DCDR). The 
increase of early visual BRD symptoms in cattle receiving vaccination on arrival did not 
translate to increased (P ≥ 0.23) morbidity rates. However, there was a numerical 
difference; 73.4% of cattle receiving RESP on-arrival required treatment for BRD 
compared to 65.1% of cattle that received delayed RESP vaccination. Furthermore, 
CLOS (P = 0.01) and RESP (P = 0.05) timing affected rectal temperature at the time of 
initial antibiotic treatment. Delaying either vaccine resulted in a greater rectal 
temperature at the time of initial antibiotic treatment. Because DCDR calves were pulled 
later than the other treatments, discrepancy in disease stage may explain the greater rectal 
temperature at the time of initial BRD treatment. There was also an impact (vaccine type 
× timing interaction, P = 0.05) on the d to treatment with the second antibiotic; DCDR 
calves were treated later (d 13 ± 1.3) than calves on the other treatments (d 9 ± 1.3). 
BVDV Type I Antibody Titers 
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 Two separate comparison methods were used to evaluate differences in BVDV 
type I titers: 1) trial-d basis and 2) equivalent-d post-RESP vaccination basis. 
Furthermore, results were analyzed and reported as either antibody concentration or 
percent positive seroconversion as described previously in the Materials and Methods.  
 Trial-Day Basis Comparison. As anticipated there was a treatment  day 
interaction (P ≤ 0.04) for BVDV type I titers for both analyses. On d 14, BVDV type I 
titer levels for ACAR were greater than ACDR (P = 0.001) or DCDR (P = 0.01, Figure 
1). On d 28, both treatments administered RESP on-arrival (ACAR and DCAR) had 
greater (P ≤ 0.005) BVDV type I titers than treatments administered delayed RESP 
vaccination (ACDR and DCDR). No treatment differences (P ≥ 0.10) existed on d 42. 
Results were similar when trial-day basis titer data were analyzed as percent 
seroconversion to BVDV type I (Figure 2). Positive seroconversion to BVDV type I was 
faster (P = 0.01) when RESP was administered on d 0. On d 14 and 28, ACAR and 
DCAR had greater percentage seroconversion than ACDR or DCDR; however, by d 42 
of the trial essentially all animals had positive seroconversion to BVDV type I.  
 Equivalent-Day, Post-RESP Comparison. There was no treatment  day 
interaction (P ≥ 0.82) for the equivalent-day post-RESP comparison method. The overall 
log2 concentration of BVDV type I antibody was 5.2, 4.9, 5.0, and 4.7 for ACAR, ACDR, 
DCAR and DCDR treatments, respectively, but not different (P = 0.68). Likewise, no 
differences (P = 0.56) were detected when analyzed as percent seroconversion by the 
equivalent-day post-RESP comparison. 
 The BVDV titer results in this study suggest that high-risk, newly received calves 
administered RESP vaccination on-arrival are able to respond adequately to RESP 
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vaccination despite the typical stress and immune challenges present during the initial 14 
d of receiving. Natural disease exposure and subsequent host immune response may have 
affected BVDV type I antibody titers; however, the extent to which this may have 
occurred is unknown. Measurement of BVDV neutralizing antibody titers has been 
reported to provide an indication of the amount of BVDV protection present in calves 
(Bolin and Ridpath, 1995) and has been positively correlated with disease prevention 
(Howard et al., 1989). Although calves administered RESP on arrival developed titers to 
BVDV type I faster, there was not a decrease (P ≥ 0.23) in morbidity or increase in 
protection as was reported in other studies (Bolin and Ridpath, 1995; Howard et al., 
1989). However, Bolin and Ridpath (1995) and Howard et al. (1989) were both BVDV 
challenge studies where calves were only exposed to BVDV; whereas in our study the 
specific agent causing morbidity was not tested and therefore unknown. In the current 
study it is likely that more than 1 viral or bacterial pathogen, or both, was causing 
morbidity, which may or may not have been vaccinated against. 
Total and Differential WBC Count 
 There was no treatment  day interaction for total WBC count (P = 0.97). There 
tended to be a main effect of CLOS timing (P = 0.08) on total WBC count (Table 5). 
Overall, delaying CLOS resulted in greater WBC counts. There was also a vaccine type  
timing interaction (P = 0.06); DCDR had greater WBC counts than ACDR (P = 0.01), 
and ACAR and DCAR were intermediate. The greater WBC levels recorded for DCDR 
may indicate that these cattle had greater occurrence of pathogenic infection. However, 
greater total WBC count may also indicate that an animal has increased ability to mount 
an innate or adaptive immune response to a foreign antigen, which is a key goal of 
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vaccination. There were effects of day of sampling on differential percentages (Figure 3), 
concentrations (data not shown), and total WBC count (Figure 4). The percentage of 
lymphocytes (quartic, P < 0.001), monocytes (quartic, P = 0.02), eosinophils (linear, P < 
0.001), and the WBC count (quartic, P < 0.001) increased as the study progressed; while 
the percentage of neutrophils decreased (quartic, P < 0.001) over time. Concentrations of 
differential WBC reacted similarly with number of neutrophils decreasing (quadratic, P < 
0.001), and numbers of lymphocytes (quadratic, P < 0.001), monocytes (quadratic, P = 
0.001), eosinophils (linear, P < 0.001), and basophils (linear, P < 0.001) increasing as the 
study progressed. Previous studies measuring total leukocytes before and after transport 
observed different results. Blecha et al. (1984) reported greater total leukocyte 
concentration at unloading and 7 d after receiving in transported steers vs. non-
transported controls. In contrast to our results, Stanger et al. (2005) observed a transient 
decrease in total leukocyte count when measured 48 h prior to, 72 h following and 216 h 
following transport of Bos indicus steers. The neutrophil:lymphocyte ratio (N:L), 
reported as an indicator of shipping stress in pigs (McGlone et al., 1993) and social stress 
in chickens (Gross and Siegel, 1983), was also affected by day of sampling (quartic, P ≤ 
0.05). As the study progressed, the N:L decreased; therefore, physiological stress early in 
the receiving period seemingly elevated the N:L ratio of calves across all treatments.  
 There were no treatment  day interactions (P ≥ 0.18) for differential percentages 
or concentrations of WBC. Overall, CLOS timing affected some differential percentages 
and concentrations. Delaying CLOS increased (P ≤ 0.02) the percentage and 
concentration of lymphocytes and decreased (P ≤ 0.05) the percentage of monocytes, and 
the percentage and concentration of eosinophils. The N:L tended to be affected by a 
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vaccine type × timing (P = 0.10) interaction; DCDR had the smallest N:L. Therefore, 
postponing both vaccines 14 d may have reduced stress.  
 Red blood cells and platelets were greatest (P = 0.02) in calves administered 
delayed RESP vaccination (Figure 4). Red blood cells (quadratic, cubic and quartic 
effects of day, P ≤ 0.05), hemoglobin (linear, quadratic, cubic and quartic effects of day, 
P ≤ 0.05), and hematocrit (quadratic and cubic effects of day, P < 0.001) were least on d 
14. Platelet concentrations were the least on d 56 (quadratic, P = 0.01). 
Serum Cortisol 
 There was no treatment  day interaction (P = 0.21) for serum cortisol 
concentrations (Figure 5), nor were there any treatment differences (P ≥ 0.53); however, 
there was a significant day effect (P = 0.002) on cortisol concentrations. Cortisol 
concentrations averaged 3.04 µg/100 mL on d 0 and declined on d 14 (2.43 µg/100 mL, P 
< 0.001) and d 28 (2.57 µg/100 mL, P = 0.01), suggesting that physiological stress was 
greatest during the first 14 d of the receiving period. Several studies report stress induced 
increases in cortisol concentrations (Kegley et al., 1997; Tyler and Cummins, 2003; 
Gupta et al., 2005), and Anglen et al. (2003) observed animals that underwent restraint 
stress failed to mount a normal immune response which resulted in increased 
susceptibility to a subsequent pathogen challenge. Crookshank et al. (1979) reported that 
corticosteroids were most responsive to transport stress; however, other trials reported no 
differences in cortisol related to weaning (Lefcourt and Elsasser, 1995) or transport 
(Galyean et al., 1981) stress. According to results of the current study, the early 
physiological stress during receiving indicated by serum cortisol concentrations, did not 
impact the ability to respond to vaccination because calves administered RESP on-arrival 
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(ACAR, DCAR) had adequate and earlier titer response to BVDV type I compared to the 
delayed RESP treatments (ACDR, DCDR). Likewise, Blecha et al. (1984) reported that 
elevated cortisol did not correlate with a suppressed immune response. 
 In conclusion, timing of vaccination did not affect ADG or health in high-risk, 
newly received calves. Antibody titers to BVDV type I developed earlier when cattle 
were administered a respiratory vaccine on d 0 vs. 14. Several differential WBC 
measures were greater when both clostridial and respiratory vaccines were delayed. This 
observation may correlate to either the occurrence of pathogenic infection or differences 
in immune status. Serum cortisol concentation was greatest during the first 14 d of 
receiving; however, cortisol level did not affect BVDV type I titer response and 
vaccination timing did not affect cortisol level.  
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Table 1. Vaccination schedule for experimental treatments 
Treatment d 0 d 14 d 28 
ACAR1 Alpha 72 / Express 53 Express 5  
ACDR4 Alpha 7 Express 5 Express 5 
DCAR5 Express 5 Alpha 7 / Express 5  
DCDR6  Alpha 7 / Express 5 Express 5 
1ACAR = arrival (d 0) clostridial and respiratory vaccination. 
2Clostridium chauvoei-septicum-novyi-sordellii-perfringens types C & D bacterin-toxoid, 
Boehringer-Ingelheim Vetmedica. 
3Bovine rhinotracheitis-virus diarrhea-parainfluenza3-respirtatory syncytial modified-live 
virus vaccine, Boehringer-Ingelheim Vetmedica. 
4ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination.  
5DCAR = delayed clostridial, and arrival respiratory vaccination. 
6DCDR = delayed clostridial and respiratory vaccination. 
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Table 2.  Ingredient composition of grain supplement (as-fed basis) 
Ingredient  % 
Corn, cracked 73.385 
Soybean meal 20 
Molasses 2 
Fat 1 
Dicalcium phosphate 0.18 
Limestone 1.8 
Salt, white 1 
Vitamin ADE premix1 0.1 
Vitamin E2 0.05 
Trace mineral premix3 0.085 
Corn / Rumensin premix4 0.4 
1Contained 8,800,000 IU Vitamin A, 1,760,000 IU Vitamin D, and 1,100 IU Vitamin E 
/kg. 
2Contained 44,000 IU/kg. 
3Contained 12% Zn, 8% Mn, 4% Cu, 500 mg Co, 2,000 mg I, and 600 mg Se/kg.  
4Provided 88 mg monensin (Elanco Animal Health, Indianapolis, IN)/kg of supplement. 
 
  
Table 3. Effect of clostridial and bovine respiratory disease vaccination timing on performance of newly received cattle 
  Contrasts1, P = 
 ACAR2 ACDR3 DCAR4 DCDR5 SEM CLOS RESP Interaction
Initial wt., kg 241 239 238 238 7.7 0.42 0.51 0.62 
Final wt., kg 295 290 291 289 7.3 0.36 0.27 0.60 
ADG, kg         
     d 0 to 14 1.10 0.94 0.96 0.94 0.20 0.64 0.54 0.65 
     d 14 to 28 1.02 0.92 0.96 0.93 0.21 0.81 0.59 0.74 
     d 28 to 42 1.02 1.04 0.92 0.96 0.22 0.42 0.80 0.95 
     d 42 to 56 0.74 0.80 0.93 0.80 0.19 0.41 0.75 0.46 
     d 0 to 56 0.98 0.93 0.95 0.91 0.07 0.62 0.34 0.87 
1CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus 
vaccination, Interaction = vaccine type × timing. 
2ACAR = arrival (d 0) clostridial and respiratory vaccination.  
3ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination. 
4DCAR = delayed clostridial, and arrival respiratory vaccination. 
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5DCDR = delayed clostridial and respiratory vaccination
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 Table 4. Effect of clostridial and bovine respiratory disease vaccination timing on health of newly received cattle 
     Contrasts1, P = 
 ACAR2 ACDR3 DCAR4 DCDR5 SEM CLOS RESP Interaction
Morbidity, % 71.4 60.7 75.3 69.5 9.6 0.36 0.23 0.72 
Day 1st treated 6 7.3 7.3 8 0.76 0.07 0.09 0.56 
Rectal temperature at treatment, ºC 40.3 40.4 40.4 40.6 0.11 0.01 0.05 0.47 
Rectal temperature 48 h after treatment, ºC 39.8a 39.9a 39.8a 39.5b 0.24 0.05 0.36 0.04 
Treated with 2nd antibiotic, %6 38.5 39.5 36.1 25.5 8.7 0.18 0.43 0.34 
Day 2nd treated 8.8b 10b 8.7b 13.1a 1.3 0.07 0.002 0.05 
Treated with 3rd antibiotic, %6 20.5 22.4 19.8 10.8 9.4 0.37 0.61 0.43 
Dead, % 1.4 1.6 3 1.5 2.4 0.67 0.7 0.64 
Chronic, % 1.5b 11.4a 6.3ab 3.2ab 4.7 0.59 0.29 0.05 
a,bMeans within a row without a common superscript are different (P < 0.05). 
1CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus 
vaccination, Interaction = vaccine type × timing. 
2ACAR = arrival (d 0) clostridial and respiratory vaccination. 
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3ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination. 
4DCAR = delayed clostridial, and arrival respiratory vaccination. 
5DCDR = delayed clostridial and respiratory vaccination. 
6Percentage of total population. 
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 Table 5. Effect of clostridial and bovine respiratory disease vaccination timing on cellular blood constituents 
      Contrasts1, P = 
 ACAR2 ACDR3 DCAR4 DCDR5 SEM CLOS RESP Interaction 
White blood cells, n  103/µL 10.3ab 9.9b 10.2ab 10.9a 0.37 0.08 0.62 0.06 
  Neutrophils, % 25 26 25 22 2.6 0.08 0.51 0.18 
  Lymphocytes, % 61 61 63 65 2.3 0.02 0.38 0.31 
  Monocytes, % 10.7 10.4 9.8 9.9 0.61 0.04 0.79 0.58 
  Eosinophils, % 2.3 1.9 1.7 1.6 0.34 0.05 0.30 0.59 
Neutrophil:lymphocyte ratio 0.55a 0.58a 0.54ab 0.45b 0.06 0.06 0.39 0.10 
Red blood cells, n  106/µL 9.7 10.3 10.0 10.4 0.25 0.34 0.02 0.51 
Platelets, K/µL 516 662 589 663 55 0.43 0.02 0.44 
a,bMeans within a row without a common superscript are different (P ≤ 0.05). 
1CLOS = main effect of timing of clostridial vaccination (d 0 vs. 14), RESP = main effect of timing of respiratory virus 
vaccination, Interaction = vaccine type × timing. 
2ACAR = arrival (d 0) clostridial and respiratory vaccination.  
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3ACDR = arrival clostridial, and delayed (d 14) respiratory vaccination. 
4DCAR = delayed clostridial, and arrival respiratory vaccination. 
5DCDR = delayed clostridial and respiratory vaccination. 
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ABSTRACT: Calves persistently infected (PI) with bovine viral diarrhea virus (BVDV) 
are a major source of the virus; however, consequences of exposure to a PI-BVDV calf in 
low-risk, single-source, preconditioned (PC) vs. high-risk, commingled, auction market 
(AM) cattle may differ. Our objective was to compare treatments of PC or AM origin, 
with (PI) or without (CON) exposure to a PI-BVDV calf in a 2 × 2 factorial arrangement 
to evaluate effects on health and performance. Four sets (block) of crossbred PC steers (n 
= 236) from 3 ranch-origins were selected randomly, weaned, dewormed, vaccinated, 
tested for PI-BVDV status, and kept on the ranch for  ≥ 42 d. Subsequently, PC steers 
were transported to a stocker receiving unit (RU), weighed (251 ± 2 kg), bled, stratified 
by d -1 BW, and assigned randomly to treatment (PCPI or PCCON) with no additional 
processing. Simultaneously, 4 sets of crossbred AM calves (n = 292) were assembled 
from regional auction markets for delivery to the RU ± 36 h from PC arrival. The AM 
calves were weighed (245 ± 1.3 kg) and administered the same processing procedures as 
PC received at their origin ranch; however, bull calves were stratified by gender and d -1 
BW, castrated surgically, then AM calves were assigned randomly to treatment (AMPI or 
AMCON). Treatment pens (0.45 ha) were arranged spatially so that PI did not have 
fence-line contact with CON. Calves were fed identically and followed the same 
antibiotic treatment protocol. Daily gain for the entire 42-d receiving trial was greater (P 
< 0.001) for PC (1.2 kg) than AM (0.85 kg). There was an exposure effect (P = 0.002) on 
ADG from d 28 to 42; CON gained 1.12 kg vs. 0.90 kg for PI. Morbidity rate was greater 
(P < 0.001) in AM (70%) than PC (7%). Treatment with a third antibiotic occurred more 
often (P = 0.04) for PI, likewise antibiotic treatment cost (P = 0.05) and the percentage of 
chronic cattle (P = 0.06) were greatest for AMPI. The BVDV type 1a titer levels were 
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greater on d 0 for PC (treatment × day, P < 0.001), and seroconversion to BVDV type 1a 
on d 0 was 100% for PC vs. 23% in AM. Circulating leukocytes were greater (P < 0.001) 
for PC on d 0, 14, and 28. The neutrophil:lymphocyte ratio was greater (P < 0.001) for 
AM on d 14 and 28. Platelet count increased transiently (P < 0.001), with greater platelets 
observed in AM (P < 0.001).  Results suggest that PC calves gain faster and require fewer 
antibiotic treatments; whereas, PI-BVDV exposure reduced gain from d 28 to 42 and 
increased the number of calves requiring a third antibiotic treatment. 
INTRODUCTION 
Bovine respiratory disease (BRD) is a multifaceted disease involving stress, 
commingling, and several viral and bacterial pathogens. Despite advances in prevention 
and control, BRD remains the leading cause of feedlot morbidity and mortality 
(Woolums et al., 2005) resulting in significant economic loss (Irsik et al., 2006) and 
reduced animal well-being. Preconditioning is a comprehensive management practice to 
prepare young calves for stocker or feedlot entry by reducing stress and improving 
disease protection through pre-arrival vaccination against BRD pathogens (Cole, 1985; 
Duff and Galyean, 2007). Preconditioned calves have reduced morbidity and improved 
gain performance compared to high-risk calves originating from auction markets (Clark 
et al., 2006; Seeger et al., 2008). Unfortunately, the estimated adoption rate of 
management factors including weaning (50.2%) or respiratory vaccination (39.4%) in US 
beef cow-calf operations remains low (USDA, 2010). 
Bovine viral diarrhea virus (BVDV) is a major culprit in the development of BRD 
either directly via acute clinical disease or through indirect effects of immunosuppression 
(Welsh et al., 1995). Furthermore, calves born persistently infected (PI) with BVDV are a 
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key source of BVDV transmission (Fulton et al., 2005), and although prevalence of PI-
BVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al., 
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen 
and adjoining pens to the virus. Research results on effects of exposure to PI-BVDV 
calves in the feedlot are conflicting; thus, the decision to invest in PI-BVDV testing of 
newly received cattle remains controversial.  One inconsistency among the literature is 
the use of cattle with varied management and health history, and research evaluating 
effects of PI-BVDV exposure in low-risk, single-source, preconditioned versus high-risk, 
commingled, auction market calves is needed to determine if outcomes differ for these 
different management systems. 
MATERIALS AND METHODS 
Cattle 
 Animal methods and experimental procedures were approved by the University of 
Arkansas Animal Care and Use Committee. 
Experimental Cattle. A total of 528 crossbred, male beef calves were used to determine 
effects of weaning management and PI-BVDV exposure. Calves from 2 different 
weaning management systems were utilized for this receiving trial; 1) low-risk, single-
source, preconditioned (PC) crossbred steer calves (n = 236; initial BW = 251 ± 2 kg) 
arrived in 4 shipment blocks from 3 Arkansas cow-calf ranches, and 2) high-risk, 
commingled, auction market (AM) crossbred bull (n = 210) and steer (n = 82) calves 
(initial BW = 245 ± 1.3 kg) that arrived in 4 shipment blocks acquired from multiple 
Arkansas auction markets. The 4 shipment blocks of PC calves originated from cow-calf 
herds located in Izard (block 1 and 4), Hempstead (block 2), and Pulaski (block 3), 
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County, AR and arrived at the University of Arkansas Agricultural Experiment Station 
located near Savoy (receiving unit; RU) on October 27, 2008, January 19, August 11, or 
December 6, 2009, respectively. The PC cattle were considered to be low-risk for 
developing BRD because they were weaned and vaccinated against BRD pathogens ≥ 42 
d prior to shipment and maintained as a single-source without commingling. Each 
shipment block of AM calves were procured and assembled by an order buyer from 2 to 3 
public auction markets located in Northwest or North Central, AR and arrived at the RU 
on October 25, 2008, January 20, August 10, or December 5, 2009 for the 4 shipment 
blocks, respectively. Order buyers were instructed to purchase AM cattle of similar BW 
and phenotype as the incoming PC block. The AM cattle were considered to be high-risk 
for developing BRD because they did not have known health or vaccination history and 
were commingled extensively resulting in greater probability of increased stress and 
exposure to BRD pathogens. 
 The main effects of management (AM or PC) and PI-BVDV exposure (not 
exposed = CON or exposed = PI) resulted in 4 treatments in a 2 × 2 factorial 
arrangement. For PC treatments, 42 to 91 d prior to trial initiation depending on block, 
randomly selected steers were weaned and ear-notched to test for PI-BVDV status at a 
commercial laboratory (Cattle Stats, LLC, Oklahoma City, OK) using the antigen-capture 
ELISA (ACE) method (Idexx Laboratories, Inc., Westbrook, ME). Also on the day of 
weaning, PC calves were administered: 1) a 5-way modified-live virus (MLV) respiratory 
vaccine containing infectious bovine rhinotracheitis, bovine viral diarrhea virus type 1a 
and 2a, parainfluenza3, and bovine respiratory syncytial virus isolates [Express 5, 
Boehringer Ingelheim Vetmedica (BIVI), St. Joseph, MO], 2) Manheimia haemolytica-
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Pastuerella multocida bacterin-toxoid (Pulmo-guard PHM-1, BIVI), and 3) pour-on or 
injectable anthelmintic (Cydectin, BIVI). Approximately 14 d later, PC calves were 
administered a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI) and re-vaccinated with 
5-way MLV respiratory vaccine. Preconditioned calves were isolated from other cattle, 
fed hay or pasture along with a supplement, and remained on their origin ranch during the 
preconditioning phase until approximately d -2 when they were shipped to the RU. Upon 
arrival to the RU, PC calves were maintained in an isolated holding pen with ad libitum 
access to hay and water until treatment allocation on d 0. On d -1, PC calves were 
weighed and returned to their isolated holding pen. The following d (d 0), PC calves were 
weighed, bled via jugular venipunture into evacuated tubes (Vacutainer; BD Inc, Franklin 
Lakes, NJ) to determine total and differential leukocytes (EDTA tube) and BVDV type 
1a antibody titers (plain tube), stratified by d -1 BW, then assigned randomly to treatment 
(PCCON or PCPI).  
 To coincide with PC groups, AM calves were assembled from regional markets 
and delivered to the RU ± 36 h from PC arrival. Upon arrival to the RU, AM calves were 
maintained in an isolated holding pen with ad libitum access to hay and water until 
treatment allocation on d 0. On d -1, AM calves were weighed, identified with a unique 
ear identification tag, ear notched to test for PI-BVDV status at a commercial laboratory 
(Cattle Stats) using the ACE method (Idexx Laboratories), and returned to their isolated 
holding pen. One AM animal in block 3 was identified as PI-BVDV and removed from 
the study pen and quarantined on d 0 of the trial. On d 0, AM cattle received the same 
vaccinations and processing procedures as described for PC on their origin ranch; 
therefore, the first known processing for AM occurred on d 0 rather than 42 to 91 d 
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previously on an origin ranch for PC. For AM calves only, re-vaccination of the 5-way 
MLV respiratory vaccine (Express 5, BIVI) occurred on d 14 in addition to 
administration of a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI). Additionally on d 
0, bull calves were castrated surgically, stratified by gender and d -1 BW, then AM calves 
were assigned randomly to treatment (AMCON or AMPI). Cattle were moved to their 
randomly assigned 0.45-ha pens and provided 0.91 kg/d (as-fed basis) of a receiving 
supplement (Table 1; 15.3% CP, DM basis) and ad libitum access to bermudagrass hay 
(13.1% CP, 64% NDF, 42% ADF, DM basis) and water. Supplement offered was step-
wise increased to a maximum of 2.73 kg/d as each pen completely consumed the 
supplement offered for 2 consecutive d.  
 All BW measurements were obtained individually without withholding feed or 
water on 2 consecutive days at the beginning (d -1 and 0) and end (d 42 and 43) of the 
receiving trial using a chute equipped with electronic load cells to determine overall 
differences in gain performance. To determine interim differences in gain performance, 
individual BW was recorded at 14-d intervals during the trial (d 14 and 28). Furthermore, 
calves were bled on d 14 and 28 to determine interim total and differential leukocytes and 
BVDV type 1a titers. Anticoagulated whole blood was collected from each animal into 
EDTA tubes, kept refrigerated (5° C), and analyzed within 24 h to determine percentage 
and concentrations (n cells/µL) of total and differential (lymphocytes, neutrophils, 
monocytes, eosinophils, and basophils) peripheral blood leukocytes (PBL), platelets, red 
blood cells, hemoglobin, and hematocrit with an automated hemacytometer (Cell-Dyn 
3500 system, Abbott Laboratories, Abbott Park, IL) standardized for analysis of bovine 
blood.  
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 Blood collected from each animal in plain evacuated tubes was centrifuged at 
2,100 × g for 20 min at 20° C, and serum was decanted into duplicate aliquots and stored 
frozen at -20° C. Subsequently, 5 sample aliquots were selected randomly from each 
treatment pen from d 0 and 28 and shipped on ice via overnight parcel service to the Iowa 
State University Veterinary Diagnostic Laboratory (ISUVDL, Ames, IA) for 
determination of serum neutralizing antibody titers against BVDV type 1a (Singer strain) 
using the virus neutralization (VN) assay. A second set of serum aliquot samples were 
pooled within day (0 and 28 only) and treatment pen, and shipped on ice via overnight 
parcel service to the Texas Veterinary Medical Diagnostic Laboratory – Amarillo 
(TVMDL, Amarillo, TX) for determination of serum neutralizing antibody titers against 
BVDV type 1a (strain NADL), 1b (strain TGAC), and 2a (strain 125). All titers were 
reported as the reciprocal of the greatest dilution of serum to provide complete protection 
of cells. For the ISUVDL analysis, the least dilution of serum tested was 1:2, whereas the 
greatest dilution tested was 1:4096. Serum that did not provide complete protection at the 
1:2 level was reported as < 2 and was considered negative for seroconversion to BVDV 
type 1a. Samples with a reported serum neutralization value of ≥ 2 were considered 
positive for seroconversion to BVDV type 1a. For the TVMDL analysis, the least dilution 
of serum tested was 1:4, whereas the greatest dilution tested was 1:1024. For both titer 
level analyses, the reported values were log2 transformed prior to statistical analysis. 
Persistently Infected Cattle. Two groups of calves that had been previously ear-notched, 
tested at a commercial laboratory (Cattle Stats), and identified as PI-BVDV according to 
ACE method were acquired from a stocker cattle operation in Washington County, OK to 
be utilized as PI-BVDV exposure sources. Upon arrival to the RU, each PI-BVDV calf 
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was ear-notched a second time, and samples were shipped via overnight parcel service to 
a different laboratory [Oklahoma Animal Disease Diagnostic Lab, Stillwater, OK or 
USDA, ARS, National Animal Disease Center (NADC), Ames, IA] for rapid re-
affirmation of positive PI-BVDV status using the same ACE procedure. Group 1 (n = 10) 
was assembled prior to trial initiation and utilized for shipment block 1 and 2; whereas, 
group 2 (n = 9) was assembled prior to beginning block 3, and utilized for block 3 and 4 
of the trial. Depending on block, 4 to 8 PI-BVDV challenge calves were assigned 
randomly to a PI-designated pen. An appropriate number of PI-BVDV calves were 
assembled for each group to allow for available alternates if an originally designated PI-
BVDV animal died. Each PI-BVDV calf that died during the trial (Group 1, n = 2; Group 
2, n = 1) was replaced immediately with a confirmed PI-positive alternate. Additionally, 
anticoagulated blood was collected from each PI-BVDV challenge animal and shipped on 
ice via overnight parcel service to NADC for subsequent differentiation of BVDV 
subgenotype strain using virus isolation of buffy coat cells and reverse-transcriptase PCR 
analysis previously described by Ridpath and Bolin (1998). The subgenotype strain of the 
2 PI-positive alternates in Group 1 was unknown. Of the PI-BVDV calves acquired for 
use as exposure sources in the current study and subgenotype confirmed, 94.7% (18 of 
19) were identified as subgenotype 1b. One PI-BVDV animal from Group 2 was 
identified as subgenotype 1a, and the pen in which this animal was assigned was removed 
from all statistical analyses. It is important to note that BVDV 1b, the subgenotype strain 
in which the PI-BVDV calves used in this experiment were identified, is the predominant 
BVDV subgenotype strain isolated from cattle in the US (Fulton et al., 2002; Ridpath et 
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al., 2010); however, currently no commercial licensed MLV respiratory vaccine in the 
US contains a BVDV 1b isolate. 
Pen Assignment and Arrangement 
 To avoid unwanted PI-BVDV fence-line contact with CON, 0.45-ha mixed-grass 
receiving pens were arranged spatially prior to treatment allocation (Figure 1). Pens 
measured 30.5 × 152 m, contained 5 m of feed bunk-line and a fence-line water source 
shared with an adjacent pen of the same treatment. Furthermore, the treatment pens were 
configured so that unlike treatment pens were separated by either a 3 m drovers, or 5 m 
feed alley. Within management group, calves were stratified by gender (AM only) and d -
1 BW, then assigned randomly to 1 of 2 or 1 of 4 PI or CON pens depending on block (8 
to 11 calves/pen) resulting in total experimental unit (pen) replication of 14, 14, 12, and 
11 for AMCON, AMPI, PCCON, and PCPI, respectively. For PI treatments, a PI-BVDV 
type 1b challenge animal was assigned randomly to each PI-designated treatment pen 
such that pens within block had an equivalent number of cattle. During all weighing and 
BRD evaluation procedures, CON treatments were evaluated first, followed by PI 
treatments to avoid unwanted CON contact with PI challenge animals or experimental 
cattle in the PI treatments, and to reduce possible exposure to fomites contaminated with 
secretory fluid or fecal material containing BVDV. 
Evaluation and Treatment of BRD 
 Calves were observed daily for clinical signs of respiratory illness (depression, 
nasal discharge, ocular discharge, cough, gaunt appearance) by 2 experiment station 
personnel with a combined 35-yr experience evaluating cattle with BRD. If ≥ 2 visual 
signs existed, calves were brought to the restraining chute, weighed, and rectal 
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temperature was recorded via a digital thermometer (GLA Agricultural Electronics; San 
Luis Obispo, CA; readability = ± 0.1°C). If rectal temperature was ≥ 40°C, cattle were 
considered morbid, administered antibiotic therapy with enrofloxacin (Baytril, Bayer 
Animal Health, Shawnee Mission, KS) at a dosage rate of 10 mg/kg of BW, and 
immediately returned to their home pen. A 48 h post-treatment interval (PTI) was 
implemented following administration of enrofloxacin, and a second temperature was 
recorded upon expiration of the initial antibiotic PTI. If the second temperature was ≥ 
40°C, a second antibiotic treatment with florfenicol (Nuflor, Schering-Plough Animal 
Health, Summit, NJ) was administered at a dosage rate of 40 mg/kg of BW. A 48 h PTI 
was also implemented for cattle administered florfenicol, and rectal temperature was 
evaluated upon expiration of the second antibiotic PTI. If the temperature was ≥ 40°C, a 
third and final antibiotic treatment with ceftiofur HCl (Excenel RTU, Pfizer Animal 
Health, New York, NY) was administered at a dosage rate of 2.2 mg/kg of BW and 
repeated for 2 consecutive days following the initial injection of ceftiofur HCl. If at any 
time rectal temperature was < 40°C, the animal was left untreated and returned 
immediately to the treatment pen until further symptoms warranted re-examination. 
Treatment data were recorded for individual animal including treatment date, rectal 
temperature, and the amount (mL) of each antibiotic administered. 
Calculations and Statistical Analyses 
 Calculations. Average antibiotic treatment cost was calculated using a fixed cost 
of $0.65/mL for enrofloxacin, $0.47/mL for florfenicol, and $0.65/mL for ceftiofur HCl. 
To determine percentage chronic, an animal was classified as chronically ill if 3 antibiotic 
treatments were administered coupled with ≤ 0.45 kg ADG for the entire 42-d trial. The 
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BRD relapse rate was determined by dividing the number of calves within each treatment 
requiring a 2nd antibiotic by the total number of calves in each treatment treated for BRD. 
 Statistical Analyses. Performance and morbidity data were analyzed as a 
randomized complete block design using the MIXED procedure of SAS (SAS Inst., Inc., 
Cary, N.C.). Pen was considered the experimental unit. The class statement included 
block (date of arrival), treatment and replicate. Block was considered a random effect in 
the statistical model. Single degree of freedom orthogonal contrasts evaluating effects of 
management (PC or AM), exposure (PI or CON), and their interaction were used. If the 
interaction was significant (P ≤ 0.10), treatment means were separated with a t-test using 
the PDIFF option in SAS. For main effects of management and exposure, a P-value ≤ 
0.05 was considered statistically significant. For repeated measures data, the model 
included treatment, day, and treatment × day. Block, treatment, day and pen were used in 
the class statement. Block was the random variable, pen within block was the subject, and 
the repeated statement was day. The covariance model structure used was AR(1). 
Contrasts for the repeated measures data included management, exposure, management × 
exposure interaction, and the linear and quadratic effect of day. 
RESULTS AND DISCUSSION 
Animal Performance 
 No treatment interactions (P ≥ 0.10) were observed for animal performance; 
therefore, only main effects of management and exposure are presented (Table 2). Single-
source PC calves had greater (P < 0.001) ADG than commingled AM calves from d 0 to 
14 (1.65 vs. 0.66 kg/d), d 0 to 28 (1.28 vs. 0.77 kg/d) and d 0 to 42 (1.20 vs. 0.85 kg/d). 
Results suggest clearly that prior vaccination against BRD pathogens and weaning 
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management that reduces psychological and physiological stress of single-source beef 
calves results in greater gain performance during a 42-d stocker receiving period. Step et 
al. (2008) evaluated effects of health and performance in beef calves from a single-source 
ranch (RANCH) either weaned and immediately shipped to a feedlot (WEAN), weaned 
and kept on the ranch for 45 d before shipment without receiving any vaccinations 
(WEAN45), weaned and kept on the ranch for 45 d before shipment and vaccinated with 
a MLV respiratory vaccine (WEANVAC45), procured and assembled through several 
auction markets (MARKET), or a commingled group (COMM) containing a portion of 
RANCH and MARKET origin cattle. Regardless of weaning or vaccination status, calves 
originating from RANCH tended to have greater ADG than COMM or MARKET calves 
for the 42-d receiving period. In a trial conducted by Clark et al. (2006), low-risk 
preconditioned calves had greater ADG during the finishing period than high-risk auction 
market calves of unknown history; however, no differences in performance were 
observed during the 28-d receiving period. Seeger et al. (2008) observed that auction 
market steers of unknown origin or health history gained 0.18 kg/d less during a finishing 
period than weaned beef calves receiving a health protocol on their origin ranch prior to 
marketing; however, an unequal number of calves testing positive for PI-BVDV 
remained in their treatment pens during the trial which may have confounded results. 
Research conducted by Pritchard and Mendez (1990) suggests that non-preconditioned 
calves may fully compensate for initial performance loss by the end of the feeding period; 
however, the non-preconditioned cattle used in that experiment would be considered low-
risk because they were maintained as a single-source and were not subjected to typical 
stressors associated with the auction market system. Further research with careful 
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consideration of experimental design is needed to determine differences in health, 
performance and the economic value of single-source PC vs. commingled AM cattle. 
 Exposure to a PI-BVDV calf in the pen resulted in inconsistent, yet interesting 
differences in performance during the 42-d receiving period. From d 0 to 28, PI-BVDV 
exposure tended (P = 0.10) to increase performance with PI-exposed calves averaging 
1.06 kg/d versus 1.00 kg/d for non-PI exposed calves. Conversely, Elam et al. (2008) 
observed a tendency for PI-BVDV exposed cattle to gain less from d 0 to 28, although 
overall ADG was not affected by PI-BVDV exposure in that study. During the final 
interim period (d 28 to 42) of our receiving trial, PI-BVDV exposure resulted in a 0.22 
kg/d decrease (P = 0.003) in ADG suggesting that negative performance consequences of 
low-virulence PI-BVDV exposure in newly received beef calves may be delayed several 
weeks. The performance loss observed from d 28 to 42 agrees with the findings of 
Hessman et al. (2009), in which cattle directly exposed to a PI-BVDV animal gained 0.15 
kg/d less than non-exposed cattle during a 66 d feedlot starter period. Reasons for our 
observation of a tendency for an increase, followed by a significant decrease in 
performance from PI-BVDV exposure are unknown; however, complex epidemiological 
and behavioral factors may have contributed. During the initial weeks of our study, PI-
BVDV calves may have unintentionally served as a trainer animal because they had been 
previously acclimated to the RU facilities. In a series of 4 trials, Loerch and Fluharty 
(2000) observed increases in eating behavior and variable ADG for newly received calves 
with a trainer cow present in the pen during the initial 14 d; however, overall (28-d) 
differences in growth were undetectable in 3 of 4 trials. Another consideration is that 
abbreviated exposure to a low-virulent BVDV strain from PI-calves could simply mimic 
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an unattenuated autogenous vaccination (Elam et al., 2008) resulting in undetectable, or 
slight performance effects during the initial weeks of PI challenge. However, as the trial 
progressed and PI-BVDV exposure continued, an additive effect on host immune activity 
may have resulted in the performance loss observed from d 28 to 42 because repeated 
immune stimulation results in nutrients being preferentially utilized for immune and 
homeostatic pathways rather than tissue deposition (Klasing and Korver, 1997; Spurlock, 
1997). Therefore, our ADG results would indicate that there may be a substantial 
metabolic cost associated with continuous exposure to a PI animal shedding a low-
virulence BVDV strain and the resulting performance loss is not immediate but rather 
several weeks subsequent when nutrients utilized for humoral and cell-mediated 
immunity associated with repeated BVDV exposure presumably reach a threshold level. 
Because BW measurements were not recorded beyond the 42-d receiving period, the 
duration of performance loss and whether there was compensatory gain during the 
finishing phase is unknown. Performance from d 0 to 42 was not affected (P = 0.29) by 
PI-BVDV exposure; however, the degree to which the slight increase in gain for PI-
exposed calves from d 0 to 28 followed by the reduction in gain of PI-exposed calves for 
the final weigh period (d 28 to 42) would have confounded the d 0 to 42 ADG results 
should be considered. Research evaluating PI-BVDV exposure effects on performance is 
both limited and conflicting; therefore, further efforts with careful consideration of 
management and health history of experimental cattle, differences in the virulence and 
subgenotype strain of PI-BVDV challenge animals, and epidemiological factors are 
needed to determine effects of PI-BVDV exposure on performance throughout the 
various stages of the beef production system. Furthermore, a better understanding of the 
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metabolic cost associated with physiological and immunological products in response to 
stress and pathogen challenge is needed. 
Animal Health 
 The BRD morbidity rate was markedly greater (P < 0.001) for AM than PC with 
70.4 and 6.7% of calves, respectively requiring treatment for BRD (Table 3). 
Furthermore, a greater number of AM calves required treatment with a second (P < 
0.001), and third (P = 0.001) antibiotic. Our BRD morbidity results were similar to Clark 
et al. (2006) in which BRD morbidity rates were 64.4 and 2.0% in steers considered 
either high- or low-risk for developing signs of BRD, respectively. Other studies 
(Macartney et al., 2003; Seeger et al., 2008), reported that calves of unknown health 
history had greater morbidity compared with those administered health protocols prior to 
marketing. Roeber et al. (2001) observed that cattle originating from preconditioning 
programs had fewer hospital visits than cattle originating from auction markets. In the 
Step et al. (2008) study described previously, morbidity was 11.1% for RANCH and 
41.9% for MARKET calves. Among the 3 RANCH-origin treatments, those weaned and 
shipped directly to the feedlot (WEAN) had greater morbidity compared to WEAN45 and 
WEANVAC45, but vaccination with a MLV respiratory vaccine at weaning did not 
reduce morbidity during the receiving period among the 2 treatments held on the origin 
ranch for 45 d. Their results would provide evidence that weaning management intended 
to reduce physiological stress had a more profound effect on subsequent morbidity than 
did administration of a MLV respiratory vaccine. 
 In the present study, antibiotic treatment cost during the 42-d receiving period 
was markedly greater (P < 0.001) for AM calves ($20.52/animal) than PC ($2.48/animal). 
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Moreover, the percentage of chronically ill cattle was increased (P = 0.03) for AM. The 
large difference observed for health parameters among the 2 cattle management sources, 
supported by other peer-reviewed research, would suggest clearly that single-source PC 
calves have fewer BRD-related health problems, improved animal well-being, and 
reduced antibiotic usage compared to commingled AM calves of unknown management 
and health history. 
 The overall BRD morbidity rate was not affected (P = 0.50) by PI-BVDV 
exposure. However, administration of a third antibiotic occurred more often (P = 0.04) 
with PI exposure and a treatment interaction (P = 0.06) was observed for the percentage 
of chronically ill animals; AMPI had the greatest number of chronically ill calves (7.6%), 
AMCON was intermediate (1.1%), and PCCON and PCPI were least (0.4 and 0.3%, 
respectively). A trend (P = 0.10) was observed for PI-exposed calves having an increased 
antibiotic treatment cost which averaged $12.59 and $10.40/animal for PI and CON 
treatments, respectively. Within AM calves only, PI exposure resulted in an antibiotic 
treatment cost of $4.06/animal more than CON; this numerical difference being similar to 
our PI-BVDV testing cost ($4.25/sample including next day parcel service fees). Our 
results would agree with a large-scale study using high-risk calves of unknown history 
(Hessman et al., 2009) in that overall morbidity was not different for direct PI-exposed or 
unexposed groups; however, percentage of first relapse, chronic illness and fatalities were 
all greater for the direct PI-exposed groups. In that trial, treatment cost/animal was not 
statistically different (P = 0.24), but a numerical increase of $1.19/animal was observed 
for direct PI-exposed groups. Loneragan et al. (2005) reported cattle exposed to a PI-
BVDV animal had a 43% greater risk of initial BRD treatment and in cattle that became 
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ill, those exposed to a PI-BVDV animal were administered more antibiotic treatments 
than non-exposed groups (1.76 vs. 1.46). Conversely, others have observed no 
differences in BRD health among PI- and non-PI-exposed pens (Booker et al., 2008; 
Elam et al., 2008); whereas, O’Conner et al. (2005) observed that disease prevalence was 
reduced in pens containing single-source cattle with a PI-BVDV calf present. Reasons for 
conflicting observations among the literature may be explained two-fold: 1) previous 
management and health history of cattle used within or among scientific experiments is 
varied; thus, susceptibility of experimental calves to PI-BVDV exposure may differ, 2) 
the virulence of BVDV strain and amount of BVDV particles shed by PI challenge 
animals varies among or within experiments. 
 Our observation of negative BRD-related health outcomes being most prevalent 
for AMPI, with few animal health differences observed among PCPI and PCCON 
treatments suggests that previous management and vaccination against BVDV and other 
respiratory pathogens may enhance protection against PI-BVDV challenge. Therefore, 
the degree to which PI-BVDV exposure affects economically important traits related to 
BRD morbidity in a stocker program or feedlot is influenced by previous management 
and health history in newly received calves, and the decision to test and remove PI-
BVDV animals from an isolated group of calves may be based in part upon the perceived 
BRD risk level. 
BVDV Antibody Titers 
 Individual Analysis. For individual samples analyzed at ISUVDL, d 0 BVDV 
type 1a (Singer strain) antibody titers were profoundly increased (treatment × day, P < 
0.001; Figure 2) for PC, and seroconversion to BVDV type 1a on d 0 was 100 and 23% 
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for PC and AM, respectively. The difference in antibody titers against BVDV type 1a on 
d 0 would indicate that AM calves were relatively naïve and PC calves had greater 
humoral immunity against either acute BVDV infection or PI-BVDV challenge. 
Serological data from previous studies indicate that greater serum antibody titers against 
BVDV upon arrival at the feedlot correspond with a subsequent reduction in risk for 
clinical BRD (Martin et al., 1999; O’Connor et al., 2001). Bolin and Ridpath (1995) 
observed that BVDV challenged calves with greater titer levels of passively acquired 
viral neutralizing antibody in serum had reduced duration and severity of clinical disease. 
In another trial (Fulton et al., 2006), vaccination with 2 doses of MLV respiratory vaccine 
containing both BVDV type 1a and 2a isolates provided protection against viremia in 
calves exposed to PI-BVDV type 2a challenge animals during a 35-d observation period. 
However, it has also been suggested that pre-existing antibodies, particularly those 
heterologous to the subgenotype strain shed by PI challenge animals may not be 
sufficient to provide complete protection (Fulton et al., 2005). 
 By d 28, BVDV type 1a titers levels were similar for all treatments; however, the 
incidence of first, second, and third BRD episode for all calves was d 2.3, 5, and 8.8, 
respectively, with few BRD episodes occurring after d 28. It should be considered that 
AM received identical vaccinations and processing procedures as PC, only the timing of 
administration differed, suggesting that MLV respiratory vaccination prior to market-
associated stress and pathogen exposure is critical to achieve sufficient antibody titer 
concentrations before the initial 14 d of receiving when BRD is most often prevalent. 
Furthermore, arrival MLV respiratory vaccination of known single-source, recently 
vaccinated PC calves may be redundant because in our experiment PC calves were not re-
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vaccinated on arrival, yet 100% were seropositive for BVDV type 1a on d 0 and BRD 
morbidity for PC calves during the 42-d receiving period was low (7.2 %). 
 Pooled Analysis. To provide field study insight on cross-reactivity of BVDV 
strains after PI-BVDV type 1b exposure, serum samples (pooled within treatment pen) 
were tested for titers against BVDV type 1a (NADL strain), BVDV type 1b (TGAC 
strain), and BVDV type 2a (125 strain) at TVMDL-Amarillo. A management effect (P < 
0.001) was observed for BVDV type 1a (Figure 3), BVDV type 1b (Figure 4), and 
BVDV type 2a (Figure 5) titers; thus, on d 0 PC had markedly greater titers compared to 
AM for all 3 BVDV subgenotypes tested. Furthermore, interactions were observed for 
BVDV 1b (P = 0.08) and BVDV type 2a (P = 0.01) antibody titers. For both 
subgenotypes, PCPI, which had not been vaccinated on d 0 of the trial, had greater serum 
antibodies on d 28 which suggests that continuous PI-BVDV challenge stimulated the 
humoral immune response in PC calves. A titer increase on d 28 was not observed for 
AMPI; however, the MLV respiratory vaccine administered on d 0 and 14 to AM calves, 
which contained BVDV 1a and 2a isolates, likely confounded the titer response to PI-
BVDV exposure. Because no interaction or exposure effect was observed for BVDV type 
1a, yet BVDV 1b titers were greatest on d 28 for PCPI calves exposed to PI-BVDV type 
1b challenge, our data would provide limited evidence that some difference in cross-
protection existed. Burciaga-Robles et al. (2010) reported increased antibody titers to 
BVDV type 1b (TGAC 8HB), but not type 1a (Singer strain) or 2a (125-C) when steers 
were exposed to 2 PI-BVDV type 1b challenge animals for 72 h and Ridpath et al. (2010) 
reported that the ratio of virus cross-neutralization among BVDV type 1a and 1b 
subgenotype strains is 36%. Therefore, increases in serum antibody titers associated with 
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PI-BVDV exposure may be dependent upon the specific subgenotype strain of PI-BVDV 
challenge. 
Hematology 
 Effects of management (P < 0.001; Table 4) and linear effects of day (P < 0.001) 
were observed for the total concentration of PBL in whole blood samples. Total PBL 
averaged 10.9 and 8.6 × 103/µL for PC and AM treatments, respectively, and PBL 
concentration increased overall with time. Treatment × day interactions were observed 
for percentage neutrophils (P = 0.002), percentage lymphocytes (P = 0.004), lymphocyte 
count (P = 0.02), and neutophil:lymphocyte ratio (P < 0.001; Figure 6). Data indicate that 
neutrophils increased for AM, but not for PC calves (management effect, P < 0.001); 
whereas, lymphocyte count and percentage increased for PC, but remained constant for 
AM as the study progressed (management effect, P < 0.001). This resulted in the overall 
neutrophil:lymphocyte ratio (N:L) being greater (P < 0.001) for AM calves; as the trial 
progressed, N:L increased for AM, but decreased for PC (treatment × day, P < 0.001). 
Other studies (Kegley et al., 1997; Ishizaki and Kariya, 2010) report transient increases in 
N:L for cattle experiencing transport stress; however, an additive effect from additional 
stressors also shown to increase N:L such as weaning (Hickey et al., 2003) and 
commingling (McGlone et al., 1993) may explain the extended duration of increased N:L 
observed for the AM calves in our study. Microbial pathogen challenge can also impact 
total and differential PBL in cattle; challenge with BVDV, Manheimia haemolytica, or 
both were shown to affect several PBL measurements (Burciaga-Robles et al., 2010). 
Further research is needed to determine the capability of PBL analysis to indicate stress 
and disease status of cattle. 
 99 
 A treatment × day interaction was observed for concentrations of red blood cells 
(P < 0.001), hemoglobin (P < 0.001), platelets (P = 0.03) and percentage hematocrit (P < 
0.001; Figure 7). A tendency for an exposure effect occurred for red blood cells (P = 
0.10), hemoglobin (P = 0.07), and hematocrit (P = 0.09); mean values for each of these 
measurements were greater for PI-exposed calves. A management effect (P < 0.001) was 
observed for platelet concentration; AM had greater platelets on d 14 and 28, which may 
indicate the presence of increased inflammation or a more stimulated cell-mediated 
immune response because platelets are an abundant source of CD154, a signaling 
molecule for T- and B-cell activation (Sowa et al., 2009). Furthermore, there was 
anecdotal evidence suggesting the association among platelet level and cell-mediated 
immune stimulation because the majority of clinical BRD symptoms occurred by d 14, 
which correlates with peak platelet levels observed on d 14. 
 In conclusion, differences in the subgenotype strain, virulence, and amount of 
BVDV particles shed by PI challenge calves, coupled with the vaccination and 
management history of a particular pen or group are key aspects that determine 
susceptibility and consequences of PI-BVDV exposure to non-PI cohorts. Study to study 
variation of these factors may explain the conflicting health and performance results in 
the published literature. Additional research considering these issues is needed to 
determine if PI-BVDV testing and removal in newly received calves is economically 
justified. Our results would suggest that costs incurred for labor, shipping, laboratory 
testing of ear-notch samples, and removal of animals identified as PI-BVDV may not 
overcome production losses for single-source, PC calves during the receiving period. 
Nevertheless, high-risk, commingled, AM cattle that are naïve and experiencing 
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physiological stress and immune modulation may warrant testing and removal of PI-
BVDV animals; however, additional research from both large-scale and randomized 
controlled trials is needed. Continuous exposure to PI-BVDV challenge during the 42-d 
receiving period reduced gain from d 28 to 42; however, it was not known the duration of 
performance loss and whether compensatory gain occurred after the 42-d receiving 
period ended. 
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Table 1.  Ingredient composition of supplement (%, as-fed basis) for newly received 
cattle 
 Maximum feeding rate 
 1.82 kg/d 2.73 kg/d 
Ingredient   
Corn, cracked 68.365 68.595 
Dried distillers grain with solubles 26 26 
Salt, white 1 1 
Limestone 2 2 
Molasses 2 2 
Vitamin A, D, E, premix1 0.15 0.09 
Trace mineral premix2 0.085 0.055 
Corn/Rumensin premix3 0.4 0.26 
1Contained 5,896,000 IU vitamin A, 1,179,200 IU vitamin D, and 15,257 IU vitamin 
E/kg. 
2Trace mineral premix contained 12% Zn, 8% Mn, 4% Cu, 500 mg of Co, 2,000 mg of I, 
and 600 mg Se/kg. 
3Provided 88 mg of monensin (Elanco Animal Health, Indianapolis, IN)/kg of 
supplement.
 Table 2. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on performance of 
newly received beef calves 
 
Auction market Preconditioned 
 
Contrast,1 P = 
Item Control PI-BVDV Control PI-BVDV SEM Management Exposure Interaction 
BW, kg 
        
  Initial 249 248 250 249 9.26 0.36 0.43 0.58 
  d 14 257 258 273 273 9.75 0.0001 0.60 0.72 
  d 28 270 270 285 286 9.09 0.0001 0.57 0.73 
  Final 286 283 301 299 7.51 0.0001 0.19 0.71 
ADG, kg 
        
  d 0 to 14 0.54 0.77 1.64 1.66 0.19 0.0001 0.16 0.20 
  d 0 to 28 0.74 0.81 1.25 1.32 0.15 0.0001 0.10 0.97 
  d 28 to 42 1.10 0.89 1.13 0.90 0.15 0.77 0.003 0.87 
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  d 0 to 42 0.86 0.84 1.21 1.18 0.10 0.0001 0.29 0.99 
1Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV 
challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure.
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Table 3. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on health of newly received beef 
calves 
 
Auction market Preconditioned Contrasts,1 P = 
Item Control PI-BVDV Control PI-BVDV SEM Management Exposure Interaction 
Morbidity, % 67.2 73.7 7.7 5.7 4.30 0.0001 0.50 0.22 
Treated once, % 33.1 30.2 3.2 0 4.00 0.0001 0.40 0.96 
Day of first treatment 3.0 2.7 2.5 0.9 1.47 0.23 0.33 0.49 
Treated twice, % 26.0 25.9 1.1 0.6 3.78 0.0001 0.94 0.95 
Day of second treatment 7.3 6.2 4.0 2.6 1.65 0.007 0.30 0.92 
Treated thrice, % 8.0 17.5 3.2 4.9 3.08 0.002 0.04 0.15 
Day of third treatment 10.7 11.1 7.1 6.1 3.07 0.08 0.90 0.76 
Relapse2, % 50.6 58.5 60.3 100 20.78 0.07 0.09 0.26 
Chronic3, % 1.1b 7.6a 0.4b 0.3b 2.26 0.03 0.07 0.06 
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Medication cost, $/calf 18.49 22.55 2.31 2.65 2.01 0.0001 0.10 0.16 
a,bMeans within a row without a common superscript are different (P < 0.05). 
1Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV 
challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure. 
2Relapse percentage calculated by dividing the number of calves within each treatment requiring a second antibiotic by the total 
number of calves in each treatment treated for BRD. 
3Cattle were classified as chronic if 3 antibiotic treatments were administered and ADG ≤ 0.45 kg for the entire 42-d trial. 
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Table 4. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly 
received beef calves 
 
Auction market Preconditioned 
 
Contrasts,1 P = 
Item Control PI-BVDV Control PI-BVDV SEM Management Exposure Interaction
Total leukocytes, n × 103/μL 8.53 8.68 10.77 10.98 0.39 0.0001 0.62 0.94 
Neutrophils, n/μL 2,344 2,407 2,599 2,403 161 0.41 0.66 0.39 
Neutrophils, % 28.4 28.5 26.1 23.4 1.22 0.002 0.27 0.24 
Lymphocytes, n/μL 4,886 5,040 6,784 7,255 358 0.0001 0.35 0.64 
Lymphocytes, % 55.3 56.1 60.2 63.6 1.60 0.0001 0.18 0.38 
Neutrophil:lymphocyte 0.64 0.67 0.53 0.45 0.04 0.0001 0.47 0.13 
Monocytes, n/μL 1,071 1,021 1,100 1,030 64.2 0.75 0.32 0.87 
Monocytes, % 13.3 12.8 10.8 10.1 0.57 0.0001 0.28 0.89 
Eosinophils, n/μL 141 120 178 185 24.0 0.03 0.75 0.52 
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Eosinophils, % 1.7 1.4 1.7 1.8 0.23 0.38 0.58 0.39 
Red blood cells, n × 106/μL 9.60 9.86 9.75 9.92 0.14 0.40 0.10 0.71 
Hemoglobin, g/100 mL 11.64 11.95 11.88 12.08 0.15 0.18 0.07 0.69 
Hematocrit, % 34.9 35.9 35.5 36.0 0.44 0.36 0.09 0.59 
Platelets, n × 103/μL 555.6 542.1 459.3 461.6 29.0 0.002 0.84 0.77 
1Management = main effect of weaning management (auction market vs. preconditioned); Exposure = main effect of PI-BVDV 
challenge (control vs. persistently infected bovine viral diarrhea virus challenge); Interaction = management × exposure. 
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Figure 1. Example (not to scale) of spatial treatment arrangement of newly received calves located at UA Experiment Station (RU).
Drover’s Alley Feed Alley 
Feed Alley 
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Figure 2. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum antibody concentrations against bovine viral diarrhea virus 
(BVDV) type 1a (Singer strain) using individual animal analysis. Effect of treatment × 
day (P < 0.001), day (P < 0.001), and management (P < 0.001). Means within a day 
without a common superscript differ (P ≤ 0.05). AMCON = auction market, control; 
AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON = 
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV 
exposure. 
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Figure 3. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum antibody concentrations against bovine viral diarrhea virus 
(BVDV) type 1a (NADL strain) using pooled analysis. Effect of treatment × day (P < 
0.001), day (P < 0.001), and management (P < 0.001). Means within a day without a 
common superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = 
auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, 
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 4. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum antibody concentrations against bovine viral diarrhea virus 
(BVDV) type 1b using pooled analysis. Effect of treatment × day (P < 0.001), day (P < 
0.001), and management (P < 0.001). A tendency (P = 0.11) was observed for exposure 
effect. Means within a day without a common superscript differ (P ≤ 0.05). AMCON = 
auction market, control; AMPI = auction market, exposed to continuous PI-BVDV 
challenge; PCCON = preconditioned, control; PCPI = preconditioned, exposed to 
continuous PI-BVDV exposure. 
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Figure 5. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum antibody concentrations against bovine viral diarrhea virus 
(BVDV) type 2 using pooled analysis. Effect of treatment × day (P < 0.001), day (P < 
0.001), and management (P < 0.001). Means within a day without a common superscript 
differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction market, exposed 
to continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI = 
preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 6. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly 
received beef calves. AMCON = auction market, control; AMPI = auction market, exposed to continuous PI-BVDV challenge; 
PCCON = preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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Figure 7. Effects of weaning management and persistently infected bovine viral diarrhea virus challenge on hematology of newly 
received beef calves. AMCON = auction market, control; AMPI = auction market, exposed to continuous PI-BVDV challenge; 
PCCON = preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure.
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CHAPTER VI 
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ABSTRACT: Calves persistently infected (PI) with bovine viral diarrhea virus (BVDV) 
are a major transmission source of the virus; however, physiological alterations resulting 
from exposure to this natural BVDV challenge model are not well understood, and the 
magnitude may differ for single-source, preconditioned (PC) vs. commingled, auction 
market (AM) cattle. Our objective was to compare treatments of PC or AM origin, with 
(PI) or without (CON) 14-d continuous exposure to a PI-BVDV calf in a 2 × 2 factorial 
arrangement to evaluate effects on total and differential leukocyte concentrations, serum 
TNF-α, IFN-γ, IL-4, IL-6 concentrations and rectal temperature (RT). Crossbred PC 
steers (n = 27) from a single ranch-origin were selected randomly, weaned, dewormed, 
vaccinated, tested for PI-BVDV status, and kept on the ranch for  61 d. Subsequently, PC 
steers were transported to a stocker receiving unit (RU), weighed (282 ± 1.6 kg), 
stratified by d -1 BW, and assigned randomly to treatment (PCPI or PCCON) with no 
additional processing. Simultaneously, a group of crossbred AM calves (n = 27) were 
assembled from regional auction markets and delivered to the RU 24 h before PC arrival. 
The AM calves were weighed (268 ± 2.3 kg) and administered the same processing 
procedures as PC received at their origin ranch; however, bull calves were stratified by 
gender and d -1 BW, castrated surgically, then AM calves were assigned randomly to 
treatment (AMPI or AMCON). Treatment pens (50 m × 15 m) were arranged spatially so 
that PI did not have fence-line contact with CON. For cytokine and hemagram analyses, 
whole blood or serum was analyzed on d 0, 1, 3, 5 (hemagram only), 7, and 14. In AM 
calves, RT increased (P < 0.001) sharply on d 1, and remained elevated until d 7. 
Exposure to PI-BVDV challenge decreased (P = 0.01) the percentage of neutrophils, and 
increased (P = 0.02) percentage lymphocytes resulting in a tendency (P = 0.07) for a 
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decreased neutrophil:lymphocyte ratio. Concentrations of TNF-α tended to increase (P = 
0.09) for PI-BVDV exposed calves. Interferon-γ concentrations on d 7 and 14, IL-6 
concentrations on d 14, and platelets on d 7 were greatest for AMPI (P ≤ 0.05). Overall, 
these results indicate effects of weaning management and PI-BVDV exposure in altering 
the immune status of newly received calves, and these effects may be additive because 
physiological alterations resulting from stress, pathogens, or both were greatest for 
AMPI. 
INTRODUCTION 
 Bovine respiratory disease (BRD) is a multifaceted syndrome involving 
physiological stress, commingling, and several viral and bacterial pathogens. 
Physiological alterations in response to individual stressors such as weaning (Hickey et 
al., 2003; Carroll et al., 2009), transportation (Blecha et al., 1984; Buckham Sporer et al., 
2008; Stanger et al., 2005), castration (Fisher et al., 1997) and commingling (Step et al., 
2009) have been observed; however, high-risk, newly received stocker cattle are often 
subjected to these stressors concurrently. Whereas, the negative effects of these stressors 
are mitigated in cattle preconditioned on their origin ranch before marketing occurs (Duff 
and Galyean, 2007). The most significant impact of physiological stress is the negative 
effect it has on feed intake and immunocompetency (Loerch and Fluharty, 1999), both of 
which may have a direct role in the development of BRD. Furthermore, acute infection 
with respiratory viruses is more likely because stress-induced immunosuppression allows 
viruses to evade host immune defense mechanisms (Sheridan et al., 1994). 
 Bovine viral diarrhea virus (BVDV) is a major culprit in the development of BRD 
either directly via acute clinical disease or through indirect effects of immunosuppression 
 121 
(Welsh et al., 1995). Furthermore, calves born persistently infected (PI) with BVDV are a 
key source of BVDV transmission (Fulton et al., 2005), and although prevalence of PI-
BVDV calves in the feedlot is estimated to be relatively low (0.3%; Loneragan et al., 
2005), a single PI-BVDV animal has the potential to continuously expose an entire pen 
and adjoining pens to the virus. Although some have observed no overall differences in 
health or performance of cohorts exposed to a PI-BVDV calf (Booker et al., 2008; Elam 
et al., 2008), continuous exposure to PI-BVDV challenge may reduce growth 
performance (Hessman et al., 2009) because repeated immune stimulation results in 
nutrients being preferentially utilized for immune and homeostatic pathways rather than 
tissue deposition (Klasing and Korver, 1997; Spurlock, 1997). We hypothesized that the 
proinflammatory cytokine response would be altered by PI-BVDV exposure; however, 
the magnitude of physiological alteration would be impacted by previous management. 
The objective of our study was to determine the serum proinflammatory cytokine 
concentration, total and differential blood leukocyte concentration, and rectal temperature 
in commingled auction market vs. single-source preconditioned calves with or without 
14-d continuous exposure to PI-BVDV challenge. 
MATERIALS AND METHODS 
Experimental Cattle 
 Animal methods and experimental procedures were approved by the University of 
Arkansas Animal Care and Use Committee. 
 Two different cattle management sources were utilized for this 14-d evaluation 
period; 1) a low-risk, single-source, preconditioned (PC) group of crossbred steer calves 
(n = 27; initial BW = 282 ± 1.6 kg) from a single origin ranch located in Izard County, 
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Arkansas and 2) a high-risk, commingled, auction market (AM) group of crossbred bull 
(n = 15) and steer (n = 12) calves (initial BW = 268 ± 2.3 kg) acquired from an Arkansas 
auction market. The PC steers arrived at the University of Arkansas Agricultural 
Experiment Station located near Savoy (receiving unit; RU) on December 6, 2009 and 
were considered to be low-risk for developing BRD because they had been previously 
vaccinated against BRD pathogens, were weaned on their origin ranch for 61 d, and 
maintained as a single-source without commingling. The AM calves were procured and 
assembled by an order buyer from a public auction market located in North Central, AR 
and arrived at the RU on December 5, 2009. The order buyer was instructed to purchase 
AM cattle of similar BW and phenotype as the incoming PC calves. The AM cattle were 
considered to be high-risk for developing BRD because they did not have known health 
or vaccination history and were commingled extensively resulting in greater probability 
of increased stress and exposure to BRD pathogens. 
 The main effects of cattle management (AM or PC) and PI-BVDV exposure (not 
exposed = CON or exposed = PI) were tested in a 2 × 2 factorial arrangement resulting in 
4 treatments. For PC treatments, 62 d prior to trial initiation, randomly selected steers 
were weaned and confirmed free of PI-BVDV via ear-notch skin samples tested for the 
presence of BVDV using the antigen-capture ELISA (ACE) method (Idexx Laboratories, 
Inc., Westbrook, ME) at a commercial laboratory (Cattle Stats, LLC, Oklahoma City, 
OK). Also on the day of weaning, PC calves were administered: 1) a 5-way modified-live 
virus (MLV) respiratory vaccine containing infectious bovine rhinotracheitis, bovine viral 
diarrhea virus type 1a and 2a, parainfluenza3, and bovine respiratory syncytial virus 
isolates [Express 5, Boehringer Ingelheim Vetmedica (BIVI), St. Joseph, MO], 2) 
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Manheimia haemolytica-Pastuerella multocida bacterin-toxoid (Pulmo-guard PHM-1, 
BIVI), and 3) pour-on anthelmintic (Cydectin, BIVI). Fourteen-d later (d -48), PC calves 
were administered a 7-way clostridial bacterin-toxoid (Alpha 7, BIVI) and re-vaccinated 
with 5-way MLV respiratory vaccine. Preconditioned calves were isolated from other 
cattle, fed hay or pasture along with a supplement, and remained on their origin ranch 
during the preconditioning phase until d -1 when they were shipped to the RU.  
 Upon arrival to the RU, PC calves were maintained in an isolated holding pen 
with ad libitum access to hay and water until treatment allocation on d 0. On d -1, PC 
calves were weighed and returned to their isolated holding pen. The following d (d 0), PC 
calves were weighed, bled via jugular venipunture into evacuated tubes (Vacutainer; BD 
Inc, Franklin Lakes, NJ) to determine total and differential leukocytes (EDTA tube) and 
serum proinflammatory cytokine concentrations (plain tube), stratified by d -1 BW, then 
assigned randomly to treatment (PCCON or PCPI). 
 To coincide with PC, AM calves were assembled from a regional market and 
delivered to the RU on d -2. Upon arrival to the RU, AM calves were maintained in an 
isolated holding pen with ad libitum access to hay and water until treatment allocation on 
d 0. On d -1, AM calves were weighed, identified with a unique ear identification tag, ear 
notched to test for PI-BVDV status at a commercial laboratory (Cattle Stats) using the 
ACE method (Idexx Laboratories), and returned to their isolated holding pen. On d 0, 
AM cattle received the same vaccinations and processing procedures as described for PC 
on their origin ranch; therefore, the first known processing for AM occurred on d 0 rather 
than 62 d previously for PC. For AM calves only, re-vaccination of the 5-way MLV 
respiratory vaccine (Express 5, BIVI) occurred on d 14 in addition to administration of a 
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7-way clostridial bacterin-toxoid (Alpha 7, BIVI). Additionally on d 0, bull calves were 
castrated surgically, stratified by gender and d -1 BW, then AM calves were assigned 
randomly to treatment (AMCON or AMPI). Cattle were then moved to their randomly 
assigned 3.7 × 29 m pens and provided 0.91 kg/d (as-fed basis) of a receiving supplement 
(15.1% CP, DM basis) and ad libitum access to bermudagrass hay (13.1% CP, 52.3% 
NDF, 40.6% ADF, DM basis) and water. Supplement offered was step-wise increased to 
a maximum of 2.73 kg/d as each pen completely consumed the supplement offered for 2 
consecutive d. All BW measurements were obtained individually without withholding 
feed or water on 2 consecutive days at the beginning (d -1 and 0) and end (d 14 and 15) 
of the receiving trial using a chute equipped with electronic load cells. 
Leukocyte and Cytokine Analyses  
 Calves were bled on d 0, 1, 3, 5, 7, and 14 to determine interim total and 
differential leukocytes. For each d, anticoagulated whole blood was collected from each 
animal into EDTA tubes, kept refrigerated (5° C), and analyzed within 24 h to determine 
percentage and concentrations (n cells/µL) of total and differential leukocytes 
(lymphocytes, neutrophils, monocytes, eosinophils, and basophils), platelets, red blood 
cells, hemoglobin, and hematocrit using an automated hemacytometer (Cell-Dyn 3500 
system, Abbott Laboratories, Abbott Park, IL) standardized for analysis of bovine blood. 
Equipment malfunction prohibited hematocrit and platelets from being analyzed on d 14. 
 Blood collected from each animal in plain evacuated tubes was centrifuged at 
2,100 × g for 20 min at 20° C, and serum was decanted into duplicate aliquots and stored 
frozen at -20° C. Subsequently, 5 sample aliquots were selected randomly on d 0, 1, 3, 7, 
and 14 from each treatment pen and transported on ice to the USDA, ARS, National 
 125 
Animal Disease Center (NADC) in Ames, IA for determination of serum 
proinflammatory cytokines TNF-α, IFN-γ, IL-4, and IL-6  using a custom bovine-specific 
multiplex ELISA assay (SearchLight, Aushon Biosytems Inc., Billerica, MA) with an 
intra- and interassay CV of 10% and 15%, respectively. 
Rectal Temperature Evaluation and Treatment of BRD 
 Rectal temperature (RT) was recorded concurrent with blood sampling via a 
digital thermometer (GLA Agricultural Electronics; San Luis Obispo, CA; readability = ± 
0.1°C) and calves were considered morbid and treated with an antibiotic based solely on 
RT. If RT was ≥ 40°C, calves were administered antibiotic therapy with enrofloxacin 
(Baytril, Bayer Animal Health, Shawnee Mission, KS) at a dosage rate of 10 mg/kg of 
BW, and immediately returned to their home pen. A 48 h post-treatment interval (PTI) 
was implemented following administration of enrofloxacin, and a second RT was 
recorded upon expiration of the initial antibiotic PTI. If the second RT was ≥ 40°C, a 
second antibiotic treatment with florfenicol (Nuflor, Schering-Plough Animal Health, 
Summit, NJ) was administered at a dosage rate of 40 mg/kg of BW. A 48 h PTI was also 
implemented for cattle administered florfenicol, and RT was evaluated upon expiration of 
the second antibiotic PTI. If the temperature was ≥ 40°C, a third and final antibiotic 
treatment with ceftiofur HCl (Excenel RTU, Pfizer Animal Health, New York, NY) was 
administered at a dosage rate of 2.2 mg/kg of BW and repeated for 2 consecutive days 
following the initial injection of ceftiofur HCl. Treatment data were recorded for 
individual animal including treatment date, RT, and the amount (mL) of each antibiotic 
administered. 
Persistently Infected Cattle 
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 Calves that had been previously ear-notched, tested at a commercial laboratory 
(Cattle Stats), and identified as PI-BVDV according to ACE method were acquired from 
a stocker cattle operation in Washington County, OK to be utilized as PI-BVDV exposure 
sources. Upon arrival to the RU, each PI-BVDV calf was ear-notched a second time, and 
samples were shipped via overnight parcel service to a different laboratory (NADC) for 
rapid re-affirmation of positive PI-BVDV status using the same ACE procedure. The PI-
BVDV challenge calves were assigned randomly to 6 PI-designated pens. Additionally, 
anticoagulated blood was collected from each PI-BVDV challenge animal and shipped on 
ice via overnight parcel service to NADC for subsequent differentiation of BVDV 
subgenotype strain using virus isolation of buffy coat cells and reverse-transcriptase PCR 
analysis previously described by Ridpath and Bolin (1998). One PI-BVDV animal was 
identified as subgenotype 1a, and the 5 remaining were subgenotype 1b. It is important to 
note that BVDV 1b, the subgenotype strain in which the PI-BVDV calves used in this 
experiment were identified, is the predominant BVDV subgenotype strain isolated from 
cattle in the US (Fulton et al., 2002; Ridpath et al., 2010); however, currently no 
commercial licensed MLV respiratory vaccine in the US contains a BVDV 1b isolate. 
Pen Assignment and Arrangement 
 To avoid unwanted PI-BVDV fence-line contact with CON, receiving pens were 
arranged spatially prior to treatment allocation. Pens measured 3.7 × 29 m, contained 3 m 
of feed bunk-line and a fence-line water source shared with an adjacent pen of the same 
treatment. Furthermore, the treatment pens were configured so that unlike treatment pens 
were separated by at least 1 unoccupied pen. Within management source, calves were 
stratified by gender (AM only) and d -1 BW, then assigned randomly to 1 of 6 PI or CON 
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pens. For PI treatments, a PI-BVDV challenge animal was assigned randomly to each PI-
designated treatment pen such that pens had an equivalent number of cattle. During all 
bleeding procedures, CON treatments were evaluated first, followed by PI treatments to 
avoid unwanted CON contact with PI challenge animals or experimental cattle in the PI 
treatments, and to reduce possible exposure to fomites contaminated with secretory fluid 
or fecal material containing BVDV. 
Statistical Analyses  
 Performance data were analyzed as a randomized complete block design using the 
MIXED procedure of SAS (SAS Inst., Inc., Cary, N.C.). Pen was considered the 
experimental unit. The class statement included treatment and replicate. Replicate was 
considered a random effect in the statistical model. Single degree of freedom orthogonal 
contrasts evaluating effects of management (PC or AM), exposure (PI or CON), and their 
interaction were used. If the interaction was significant (P ≤ 0.10), treatment means were 
separated with a t-test using the PDIFF option in SAS. For main effects of management 
and exposure, a P-value ≤ 0.05 was considered statistically significant. For morbidity 
data, the class statement included treatment and pen. Pen was considered a random effect. 
For repeated measures data, the model included treatment, day, and treatment × day. 
Kenward Roger was specified as the degrees of freedom selection method. Treatment, 
day, replicate, pen and animal were used in the class statement. Replicate was the random 
variable, animal was the subject, and the repeated statement was day. The covariance 
model structure used was SP(POW). Contrasts for the repeated measures data included 
management, exposure, and management × exposure interaction. 
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RESULTS AND DISCUSSION 
Rectal Temperature  
 Mean RT for AM calves increased sharply (treatment × day interaction; P < 
0.001) upon trial initiation and remained elevated until reaching baseline on d 14 such 
that a main effect of management (P < 0.001) was evident (Figure 1). Febrile RT 
responses have been consistently reported in experimental models of viral (Chirase et al., 
1991; Muller-Doblies et al., 2004), endotoxin (Reuter et al., 2008) and corticotrophin-
release hormone (Cooke and Bohnert, 2011) challenge. Furthermore, RT ≥ 40°C is a 
standard objective index used to determine clinical BRD morbidity of cattle both in the 
production setting (Edwards, 2010) and in the current study. Peak RT was observed on d 
1, averaging 40.3 and 39.1°C for AM and PC, respectively. The elevated RT in AM 
corresponded with markedly greater (management effect; P < 0.001) morbidity for AM 
(86%) vs. PC (4%) during the 14-d evaluation period; consequently, antibiotic treatment 
cost was $23.25 vs. $1.53/animal for AM and PC, respectively. 
 The greater RT observed for AM may be in response to physiological stress, 
disease pathogens, or both; however differentiation of the febrile response is difficult to 
determine. Nevertheless, PI-BVDV challenge did not affect (P = 0.95) RT in our study; 
thus, the increased rectal temperature observed for AM but not PC treatments was likely 
due to greater physiological stress or acute effects of viral or bacterial pathogens 
encountered by AM cattle during the marketing process. Others reported RT being 
increased subsequent to PI-BVDV challenge (Burciaga Robles et al., 2010) or oral 
inoculation of BVDV (Muller-Doblies et al., 2004); however, the sampling intervals were 
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earlier and more concerted in these studies and differences in RT that may have occurred 
between sampling intervals in the current study are unknown. 
Total and Differential Leukocytes 
 A main effect of management (P = 0.01) and a treatment × day interaction (P < 
0.001) was evident for total leukocytes (Figure 2). Total leukocytes were less for AM 
cattle (management effect; P = 0.01) whereas, AMCON had the lowest concentration of 
circulating leukocytes on d 5, 7, and 14 (trt × day; P ≤ 0.05). Total leukocytes did not 
differ (P = 0.17) for PI compared to CON. In a previous study, total leukocytes were 
reduced in steers exposed to PI-BVDV challenge only, yet total leukocytes were 
increased when concurrently challenged with M. haemolytica (Burciaga-Robles et al., 
2010). A frequent outcome of stress- or viral-induced immunosuppression is severe or 
fatal bacterial pneumonias (Panciera and Confer, 2010). However, the degree to which 
experimental animals in the current study were infected with pathogenic bacteria such as 
M. haemolytica, and potentially confounding affects on leukocyte concentrations was 
unknown. 
 The percentage of neutrophils were less (P = 0.01; Figure 3), and the percentage 
of lymphocytes greater (P = 0.02; Figure 4) in calves exposed to PI-BVDV challenge 
than CON. Consequently, a trend (P = 0.07) was observed for neutrophil:lymphocyte 
(N:L) ratio (Figure 5) being less in calves exposed to a PI-BVDV calf. Similarly, 
Burciaga-Robles (2010) reported neutrophils were less in steers exposed to PI-BVDV 
challenge only; however, when PI-exposed steers were challenged with M. haemolytica, 
neutrophils were increased. In our study, cattle management also affected (P = 0.02) N:L 
ratio; AM calves had greater N:L ratio than PC. Although neutrophils were not reported, 
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Gupta et al. (2005) observed decreased lymphocytes after steers were subjected to 6 
regrouping and repenning events intended to induce physiological stress. Other studies 
reported transient increases in N:L for cattle experiencing transport (Kegley et al., 1997; 
Ishizaki and Kariya, 2010), weaning (Hickey et al., 2003), and commingling (McGlone et 
al., 1993) stress. Therefore, the increased N:L ratio would indicate greater stress for AM 
compared to PC. 
 On d 3, the percentage of monocytes was greatest for AMCON, intermediate for 
AMPI, and least for PCCON and PCPI (Trt × day; P = 0.01). A treatment × day 
interaction (P < 0.001) was observed for platelet concentrations. On d 1, platelets were 
greatest for PCPI, intermediate for PCCON and AMPI, and least for AMCON (P ≤ 0.05; 
Figure 6). However, on d 7 this pattern was inverted; AMPI had the greatest platelets, 
AMCON was intermediate, and PCPI and PCCON were least (P ≤ 0.05). Platelets are 
well known for their role in inflammation and hemostasis (George, 2000); however, their 
function and response to disease challenge or physiological stress are less clear. Sowa et 
al. (2009) proposed platelets as a potential modulator of adaptive immunity because they 
may enhance antigen presentation. Further investigation on the platelet response to 
physiological stress and disease in beef cattle seems warranted. 
Serum Cytokines 
 Serum TNF-α concentration tended (P = 0.09) to be greater in calves exposed to 
PI-BVDV challenge (Figure 7). There were no main effects of cattle management on 
serum proinflammatory cytokine concentrations in the current study. Day effects (P ≤ 
0.001) were observed for TNF-α, IFN-γ, IL-4 and IL-6; concentrations increased 
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transiently with time. Other than a day effect, no differences were observed for serum IL-
4 concentration (Figure 9). 
 A treatment × day interaction was observed for concentrations of IFN-γ (P = 
0.05) and IL-6 (P = 0.006; Figure 8 and 10, respectively). Peak IFN-γ concentrations 
occurred on d 7 and were 3.3-fold greater in AMPI than PCCON (P = 0.004). By d 14, 
overall IFN-γ concentrations had decreased (day effect; P = 0.001); nevertheless, AMPI 
was greatest, PCPI was intermediate, and AMCON and PCCON were least. 
 Peak concentrations of IL-6 were observed on d 1 and rapidly returned to near 
baseline levels by d 3; nevertheless, a treatment × day interaction (P = 0.006) was 
evident. On d 1, IL-6 concentrations were greatest for AMCON, intermediate for AMPI 
and PCPI, and least in PCCON. By d 14, AMPI had greater serum concentrations of IL-6 
compared to AMCON.  
 Similar to our results of increased TNF-α, IFN-γ and IL-6 for PI-exposed 
treatments, Burciaga-Robles et al. (2010) observed increases in TNF-α, IFN-γ, and IL-6 
when steers were exposed 72 h to 2 PI-BVDV calves. Carroll et al. (2009) observed that 
both TNF-α and IL-6 concentrations increased following endotoxin challenge in calves, 
and the magnitude of increase was greater for calves weaned at 250 d  of age versus 
early-weaned at 80 d of age and shipped simultaneously to a receiving facility. 
Proinflammatory cytokine concentrations being greater for AMPI and PCPI suggests a 
more stimulated immune response via continuous PI-BVDV exposure that may 
consequently affect growth performance (Spurlock, 1997). Although differences in 
growth were not observed in this 14-d trial, evidence from a companion study (Chapter 
V) suggests that effects of PI-BVDV exposure are often sub-acute, and consequences on 
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growth performance may be delayed for several weeks, beyond the 14-d evaluation 
period herein. 
 In conclusion, continuous PI-BVDV exposure may decrease growth performance 
because the repeated immune stimulation increases proinflammatory cytokines IFN-γ, 
TNF-α, and IL-6 that can impair growth either directly by acting on tissues, or indirectly 
through their effects on the endocrine system (Klasing and Korver, 1997). Differences in 
hematological variables, particularly neutophil:lymphocyte ratio, may also indicate 
differences in physiological stress and disease in newly received beef calves. 
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Figure 1. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on mean rectal temperature of newly received beef calves. Effect of 
treatment × day (P < 0.001), day (P < 0.001), and management (P < 0.001). Means 
within a day without a common superscript differ (P ≤ 0.05). AMCON = auction market, 
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON = 
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV 
exposure. 
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Figure 2. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on blood leukocyte concentrations of newly received beef calves. Effect 
of treatment × day (P < 0.001), day (P = 0.005), and management (P = 0.01). Means 
within a day without a common superscript differ (P ≤ 0.05). AMCON = auction market, 
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON = 
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV 
exposure. 
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Figure 3. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on percent neutrophils in blood of newly received beef calves. Effect of 
treatment × day (P < 0.001), day (P < 0.001), and exposure (P = 0.01). A tendency (P = 
0.07) was observed for management effect. Means within a day without a common 
superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction 
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control; 
PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 4. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on percent lymphocytes in blood of newly received beef calves. Effect of 
treatment × day (P < 0.001), day (P < 0.001), and exposure (P = 0.02). A tendency (P = 
0.10) was observed for management effect. Means within a day without a common 
superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = auction 
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control; 
PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 5. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on blood neutrophil:lymphocyte ratio of newly received beef calves. 
Effect of treatment × day (P < 0.001), day (P < 0.001), and management (P = 0.02). A 
tendency (P = 0.07) was observed for management effect. Means within a day without a 
common superscript differ (P ≤ 0.05). AMCON = auction market, control; AMPI = 
auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, 
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 6. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on blood platelet concentration of newly received beef calves. Effect of 
treatment × day (P < 0.001) and day (P < 0.001). Means within a day without a common 
superscript are different (P ≤ 0.05). AMCON = auction market, control; AMPI = auction 
market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, control; 
PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 7. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum tumor necrosis factor-α concentration of newly received beef 
calves. Day effect (P < 0.001). A tendency (P = 0.09) was observed for an exposure 
effect. AMCON = auction market, control; AMPI = auction market, exposed to 
continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI = 
preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 8. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum interferon-γ concentration of newly received beef calves. Effect 
of treatment × day (P = 0.05) and day (P = 0.001). Means within a day without a 
common superscript are different (P ≤ 0.05). AMCON = auction market, control; AMPI 
= auction market, exposed to continuous PI-BVDV challenge; PCCON = preconditioned, 
control; PCPI = preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 9. Effects of weaning management and persistently infected bovine viral diarrhea 
virus challenge on serum interleukin-4 concentration of newly received beef calves. Day 
effect (P < 0.001). AMCON = auction market, control; AMPI = auction market, exposed 
to continuous PI-BVDV challenge; PCCON = preconditioned, control; PCPI = 
preconditioned, exposed to continuous PI-BVDV exposure. 
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Figure 10. Effects of weaning management and persistently infected bovine viral 
diarrhea virus challenge on serum interleukin-6 concentration of newly received beef 
calves. Effect of treatment × day (P = 0.006) and day (P < 0.001). Means within a day 
without a common superscript are different (P ≤ 0.05). AMCON = auction market, 
control; AMPI = auction market, exposed to continuous PI-BVDV challenge; PCCON = 
preconditioned, control; PCPI = preconditioned, exposed to continuous PI-BVDV 
exposure.   
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CHAPTER VII 
 
CONCLUSION 
 A series of experiments were conducted to determine the effects of on-arrival vs. 
delayed respiratory vaccination and exposure to persistently infected bovine viral 
diarrhea virus challenge on health, gain performance, and physiological and 
immunological measurements in newly received stocker cattle. Two experiments 
evaluated timing (d 0 vs. 14) of respiratory, clostridial, or both vaccinations in newly 
received stocker calves during stress-induced immunosuppression. In Exp. 1, calves 
receiving 14-d delayed vaccination of a pentavalent modified-live respiratory virus 
(MLV) vaccine had greater ADG during the 42-d receiving period and antibody titers 
against infectious bovine rhinotracheitis on d 42; however, morbidity rate did not differ. 
In the second study, stress indicated by serum cortisol concentration and 
neutrophil:lymphocyte ratio was greatest on d 0; nevertheless, no differences in 
performance or morbidity were observed for vaccination treatments. Both studies 
provided evidence that on-arrival administration of a pentavalent MLV respiratory 
vaccine to immunocompromised cattle does not mitigate clinical bovine respiratory 
disease (BRD) or improve animal performance because the majority of clinical 
respiratory disease for both studies occurred during the first 14-d and morbidity rate was 
not different when calves were vaccinated on d 0 vs. 14. 
 A third trial was performed to determine the effects of weaning management and 
subsequent exposure to persistently infected (PI) bovine viral diarrhea virus (BVDV) 
challenge on health, performance, bovine viral diarrhea virus titers, peripheral blood 
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leukocytes, and inflammatory cytokines. The objective was to compare treatments of 
preconditioned (PC) or auction market (AM) origin, with (PI) or without (CON) 
continuous exposure to PI-BVDV type 1b challenge in a 2 × 2 factorial arrangement to 
evaluate main effects of management, exposure, and their interaction on health 
parameters and growth performance during a 42-d receiving trial. Preconditioned calves 
that were vaccinated, castrated, and weaned at their origin ranch had greater gain 
performance and reduced BRD morbidity compared to AM calves with unknown history. 
Furthermore, PC cattle had greater antibody titers to BVDV type 1a on d 0, and 
neutrophil:lymphocyte ratio and platelet count were lower during the 42-d receiving 
period. Exposure to PI-BVDV challenge reduced gain from d 28 to 42, perhaps due to an 
additive effect of continuous immune stimulation resulting in nutrients being 
preferentially utilized for immune pathways rather than tissue deposition. A treatment 
interaction was observed for the percentage of chronically ill animals; AMPI had the 
greatest number of chronically ill calves (7.6%), AMCON was intermediate (1.1%), and 
PCCON and PCPI were least (0.4 and 0.3%, respectively). These results would suggest 
that costs incurred for labor, shipping, laboratory testing of ear-notch samples, and 
removal of animals identified as PI-BVDV may not overcome losses in health or 
performance of single-source, PC calves during the receiving period. However, high-risk, 
commingled, AM cattle that are naïve and experiencing physiological stress and 
immunosuppression may warrant testing and removal of PI-BVDV animals. 
 During a 14-d evaluation period (trial 4), exposure to PI-BVDV challenge 
increased serum TNF-α concentrations, and IFN-γ concentrations on d 14 were greatest 
for AMPI, intermediate for PCPI, and least for AMCON and PCCON. The increased 
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cytokine concentrations associated with PI-BVDV exposure illustrate a more stimulated 
immune response which has implications for animal health due to taxation of the immune 
system and growth due to a homeorhetic response in which nutrients may be 
preferentially shifted towards immune function rather than tissue growth. 
